![[ Visit Client Website ]](images/banner.jpg)
2016 AAAAI Annual Meeting
Thursday, March 3, 2016
7:20 AM-5:00 PM
0001
30th Annual Harold S. Nelson Military Allergy/Immunology Symposium TICKETED
Session Details
Session Details
Thursday, March 3, 2016: 7:20 AM-5:00 PM
JW Marriott, Gold Ballroom Level, Salon 2
8.25 CME/CE
Moderator:
Karla L. Davis , MD FAAAAI
Learning Objectives:
- Discuss the approach to identifying and evaluating a patient with eosinophilic esophagitis
- Identify and discuss therapies for patients with eosinophilic esophagitis
- Discuss the approach to identifying and evaluating a patient with aspirin-exacerbated respiratory disease
8:00 AM-5:00 PM
0101
CEGIR/TIGERS EGID Symposium TICKETED
Session Details
Session Details
Thursday, March 3, 2016: 8:00 AM-5:00 PM
JW Marriott, Platinum Ballroom Level, Salon DE
7.25 CME/CE
Course
Learning Objectives:
- Describe the diagnostic criteria for EoE, eosinophilic gastritis/gastroenteritis/colitis and the controversies in diagnosis
- Review the successful current therapeutic options for EoE and review the current triggers for EGIDs
- Discuss the pathogenesis as it relates to specific cellular subtypes such as mast cells, eosinophils and T cells
9:00 AM-12:00 PM
0201
Advanced Course in Pollen Identification TICKETED
Session Details
Session Details
Thursday, March 3, 2016: 9:00 AM-12:00 PM
JW Marriott, Gold Ballroom Level, Salon 3
3.00 CME/CE
Course
Moderator:
Estelle Levetin , PhD FAAAAI
Learning Objectives:
- Differentiate pollen in the birch family and related triporate pollen types
- Discuss difficult to identify tricolporate pollen types
- Differentiate Asteraceae pollen, other than ragweed
12:15 PM-1:15 PM
0101A
0101I
0101J
Ask the Experts: EoE Open Mic TICKETED
Session Details
Session Details
Thursday, March 3, 2016: 12:15 PM-1:15 PM
JW Marriott, Platinum Ballroom Level, Salon DE
1.00 CME/CE
Course
Moderator:
Marc E. Rothenberg , MD PhD FAAAAI
2:00 PM-5:00 PM
0601
Advanced Course in Fungal Spore Identification TICKETED
Session Details
Session Details
Thursday, March 3, 2016: 2:00 PM-5:00 PM
JW Marriott, Gold Ballroom Level, Salon 3
3.00 CME/CE
Course
Moderator:
Estelle Levetin , PhD FAAAAI
Learning Objectives:
- Differentiate common basidiospores
- Differentiate common ascospores
- Differentiate Fusarium, Penicillium/Aspergillus and other difficult spore types
6:30 PM-8:30 PM
Taking a Broader View: Enhancing Evaluation and Care for Patients with Primary Immunodeficiency
Session Details
Session Details
Thursday, March 3, 2016: 6:30 PM-8:30 PM
JW Marriott, Platinum Ballroom Level, Salon ABC
0.00 CME/CE
Friday, March 4, 2016
7:00 AM-9:30 AM
1001
Allergen Immunotherapy, Today and Tomorrow: Session I. Inhalant Allergens for Allergic Rhinitis and Asthma
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level One, Petree Hall C
2.50 CME/CE
Course
Moderator:
Alkis Togias , MD FAAAAI
Learning Objectives:
- Discuss current and future approaches to allergen immunotherapy for asthma and allergic rhinitis
- Discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens
- Discuss the durability of immune unresponsiveness induced by allergen immunotherapy
1002
Difficult Cases
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level One, Petree Hall D
2.25 CME/CE
Course
Primary Moderators:
Amber M. Patterson , MD FAAAAI
Joyce E. Yu , MD FAAAAI
Joyce E. Yu , MD FAAAAI
Learning Objectives:
- Discuss diagnostic and clinical management challenges encountered in allergy, asthma and immunology practice
1003
Is it Possible to Reprogram a Broken Immune System? How Translational Research is Shifting the Treatment Paradigm from Symptom Management to Cure
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level Two, Room 404AB
2.50 CME/CE
Course
Moderator:
Kathryn E. Hulse , PhD
Learning Objectives:
- Discuss how genetic factors and the environment interact to determine allergic sensitization
- Identify potential targets for prevention and treatment
- Discuss different types of treatment for allergic diseases
1004
Markers of Allergic Inflammation
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level Two, Theatre (Room 411)
2.50 CME/CE
Course
Moderator:
Dean D. Metcalfe , MD FAAAAI
Learning Objectives:
- Describe the surrogate markers of mast cell, eosinophil and basophil activation
- Describe the most reproducible and specific markers
- Describe laboratory testing and use of surrogate markers of inflammation in clinical studies
1006
Masqueraders of Anaphylaxis/Angioedema
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level Two, Room 408B
2.50 CME/CE
Course
Moderator:
Michael M. Frank , MD FAAAAI
Learning Objectives:
- Describe uncommon causes of anaphylaxis-type symptoms and angioedema, including HAE, Gleich syndrome, familial tryptasemia/mast cell activation syndromes, idiopathic anaphylaxis and the systemic capillary leak syndrome
- Describe the cutting-edge research regarding the biology of rarer causes of anaphylactic symptoms and angioedema
- Discuss how this new information can be applied to understanding anaphylactoid symptoms in humans and how these cell types can potentially be modulated to treat patients
1007
Endoscopic Evaluation and Management of Chronic Rhinosinusitis (Pre- and Post-Surgery) Including Cultures
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level Two, Room 409AB
2.50 CME/CE
Course
Moderator:
Jerald W. Koepke , MD FAAAAI
Learning Objectives:
- Describe the anatomy of the paranasal sinuses with specific focus on structures that are of pathophysiological and surgical relevance
- Discuss radiological modalities and their usage in CRS diagnosis
- Describe typical radiological findings in CRS and the usage and limitations of endoscopic evaluation of the nose and sinuses before and after surgery
1008
Pathogenesis of Chronic Rhinosinusitis
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level Two, Room 502A
2.50 CME/CE
Course
Moderator:
Tanya M. Laidlaw , MD FAAAAI
Learning Objectives:
- Discuss the role of TSLP and its metabolic products in the inflammation of nasal polyps
- Recognize the mechanisms by which IL-33 contributes to the pathogenesis of CRS with nasal polyps and the potential to target this cytokine in therapy
- Identify the mechanisms by which PGD2 directs inflammation in rhinosinusitis and nasal polyps and become aware of unique aspects of the pathology and pathophysiology of nasal polyp disease in Asia and in Europe
1009
Best Social Media Practices for Allergists: How to be a Social Media Superstar TICKETED
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level Two, Room 405
2.50 CME/CE
Course
Moderator:
Giselle Mosnaim , MD MS FAAAAI
Learning Objectives:
- Discuss how to setup a Twitter account and learn how to use it to connect with patients and colleagues
- Discuss how to setup a Facebook professional page and learn how to use it to connect with patients and colleagues
- Identify what a free blog is and learn how to use YouTube to embed and record videos to maintain an interactive website for your practice
1010
Problem-Based Learning: COPD Overlap Syndrome TICKETED
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-9:30 AM
Convention Center, Level Two, Room 518
2.50 CME/CE
Course
Learning Objectives:
- Describe the diagnostic criteria for COPD and asthma
- Discuss how these entities may overlap in some patients
- Describe how to incorporate older and newer therapeutic options for these patient groups
7:00 AM-1:45 PM
1012
FIT Symposium TICKETED
Session Details
Session Details
Friday, March 4, 2016: 7:00 AM-1:45 PM
JW Marriott, Diamond Ballroom Level, Salon 5
0.00 CME/CE
Symposium
Moderator:
Becky J. Buelow , MD
Learning Objectives:
- Discuss the mechanisms of asthma
- Describe the advances of treatment in childhood asthma
- Discuss the biologic treatments of asthma and how these relate to different asthma phenotypes
7:30 AM-1:45 PM
1050
(Invite Only) Chrysalis Project Program TICKETED
Session Details
Session Details
Friday, March 4, 2016: 7:30 AM-1:45 PM
JW Marriott, Diamond Ballroom Level, Salon 4
0.00 CME/CE
Other
8:00 AM-9:15 AM
1101
Allied Health: Should Allergists and Otolaryngologists Practice Together?
Session Details
Session Details
Friday, March 4, 2016: 8:00 AM-9:15 AM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Workshop
Moderator:
John D. Milewski , FACMPE, MSHA
Learning Objectives:
- Describe further reductions in practice costs through overall size, producing volume discounts and superior reimbursement profiles
- Describe innovative time and money saving initiatives like the implementation of a central mixing facility
- Discuss the financial advantages resulting from the proximate and plentiful internal referral resources or opportunities available to both allergists and otolaryngologists
8:00 AM-12:30 PM
1102
Allied Health: Advanced Practice Course
Session Details
Session Details
Friday, March 4, 2016: 8:00 AM-12:30 PM
Convention Center, Level Two, Room 515A
4.00 CME/CE
Course
Moderator:
Nina A. Zimmermann , MSN RN ANP-BC AE-C
Learning Objectives:
- Apply current evidence-based information to clinical practice
9:30 AM-10:45 AM
1151
Allied Health: Marketing for the Allergy Practice
Session Details
Session Details
Friday, March 4, 2016: 9:30 AM-10:45 AM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Workshop
Moderator:
John D. Milewski , FACMPE, MSHA
Learning Objectives:
- Discuss the importance of marketing in an allergy practice
- Identify how to develop a marketing plan
- Discuss the use of electronic media for marketing
10:00 AM-12:30 PM
1201
Allergen Immunotherapy, Today and Tomorrow: Session II. Immunotherapy with Food Allergens
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level One, Petree Hall C
2.50 CME/CE
Course
Moderator:
Marshall Plaut , MD FAAAAI
Learning Objectives:
- Discuss current and future approaches to allergen immunotherapy for food allergy
- Discuss the potential mechanisms by which immunotherapy modulates the immune response to allergens
- Discuss the durability of immune unresponsiveness induced by allergen immunotherapy or by ingestion of food allergens beginning in infancy
1202
Diagnostic Challenges in Mastocytosis: Serum Tryptase, Allele-Specific PCR and GI Pathology
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level One, Petree Hall D
2.50 CME/CE
Course
Moderator:
Catherine R. Weiler , MD PhD FAAAAI
Learning Objectives:
- Discuss utility and interpretation of elevated tryptase level
- Discuss which cases can be evaluated at general allergist level and when a referral to a mastocytosis center is indicated
- Discuss utility and interpretation of allele-specific PCR and indications for bone marrow biopsy
1203
NIEHS: Autophagy and Phagocytosis: At the Crossroads of Inflammation and Tolerance
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 404AB
2.50 CME/CE
Course
Moderator:
Jennifer Martinez , PhD
Learning Objectives:
- Identify the role of phagocytosis and autophagy in the modulation of the innate immune response
- Discuss the role of the autophagy machinery in antigen presentation and modulation of the adaptive immune response
- Examine the role of phagocytosis and autophagy in the pathogenesis of autoimmune disorders
1204
Introductory Course in Rhinolaryngoscopy with Hands-On Instruction TICKETED
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 407
2.50 CME/CE
Course
Moderator:
Jerald W. Koepke , MD FAAAAI
Learning Objectives:
- Describe the surgical anatomy of the upper airway, including the nasal cavity, pharynx and larynx
- Identify examples of normal and abnormal anatomy, as well as disease presentations and post-operative changes found with endoscopic examination of the upper airway
- Identify indications for and the use of the fibreoptic rhinoscope in the allergist´s office
1205
Lessons from Functional Genomics: New Data from the AADCRC
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 408A
2.50 CME/CE
Course
Moderator:
Angela Haczku , MD PhD FAAAAI
Learning Objectives:
- Discuss the new information available about the genetic regulation of allergic disease that can be practically applied to patient care
- Discuss the most recent data from large population cohorts that inform our therapeutic approach
- Discuss new insights into ORMDL3 and allergic disease
1206
Inflammatory Origins of CRS: Uncovering Opportunities for Disease Prevention and Modification
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 408B
2.50 CME/CE
Course
Moderator:
David W. Hauswirth , MD FAAAAI
Learning Objectives:
- Describe the role of the microbiome and biofilms in the development of CRS
- Discuss the implications of antibiotic use and overuse in CRS
- Identify inflammatory pathways in CRS and opportunities for disease modification
1207
How to Apply for and Obtain an NIH Grant for the New Investigator TICKETED
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 405
2.50 CME/CE
Course
Moderator:
Larry Borish , MD FAAAAI
Learning Objectives:
- Describe the system of NIH funding mechanisms
- Critically evaluate grant applications
1208
Finding a Job and Getting Started in Practice
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 502A
2.50 CME/CE
Course
Moderator:
Weily Soong , MD FAAAAI
Learning Objectives:
- Discuss the changing landscape of American medicine and the practice of allergy
- Explain how to identify and join the right practice opportunity
- Discuss the fundamentals of office management, identify strategies for marketing a practice, and review tips on building a patient base
1209
Making Your Technology Work for You
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 502B
2.50 CME/CE
Course
Moderator:
Anne K. Ellis , MD MSc FAAAAI
Learning Objectives:
- Discuss how technology can assist in work flow from the beginning to the end, utilizing the EMR to the fullest
- Discuss social media and marketing tools for the practice
- Discuss and provide an introduction to telemedicine
1210
The Principles of Healthy Homes and Using Home Environmental Assessment in Disease Management
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level One, Concourse Hall Room 152
2.50 CME/CE
Course
Moderator:
James W. Sublett , MD
Learning Objectives:
- Recognize potentially harmful respiratory exposures in homes including allergens, mold, pests, particulate, and other pollutants
- Identify the seven principles of healthy housing
- Describe how to collaborate with environmental professionals to make healthy homes a reality
1211
NHLBI: Incorporating New Methodology in Asthma Clinical Trials TICKETED
Session Details
Session Details
Friday, March 4, 2016: 10:00 AM-12:30 PM
Convention Center, Level Two, Room 515B
2.50 CME/CE
Course
Moderator:
Christine A. Sorkness , PharmD
Learning Objectives:
- Discuss how the age of the study population affects asthma clinical trials
- Discuss the process of data collection for biologic specimens and clinical data in asthma trials
- Discuss how data is converted into clinically meaningful information for patients with asthma
11:00 AM-12:15 PM
1301
Allied Health: The Allergist's Coding Update for 2016
Session Details
Session Details
Friday, March 4, 2016: 11:00 AM-12:15 PM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Workshop
Moderator:
Joan E. Hawkins , CMM
Learning Objectives:
- Discuss what is new in coding this year
- Discuss awareness of allergy testing and serum dosing limits
- Identify the rules for physician extender billing and state variations
12:00 PM-1:00 PM
Credentials Committee
Session Details
Session Details
Friday, March 4, 2016: 12:00 PM-1:00 PM
Convention Center, Level Two, Room 303A
0.00 CME/CE
12:00 PM-1:45 PM
Program Directors Assembly Business Meeting
Session Details
Session Details
Friday, March 4, 2016: 12:00 PM-1:45 PM
JW Marriott, Platinum Ballroom Level, Salon C
0.00 CME/CE
12:30 PM-1:45 PM
1351
Poster Discussion Workshop: Cellular Effectors of Allergy and Disturbed Immunity
Session Details
Session Details
Friday, March 4, 2016: 12:30 PM-1:45 PM
JW Marriott, Platinum Ballroom Level, Salon D
Oral Session
1.25 CME/CE
Primary Moderators:
Kathryn E. Hulse , PhD
Zoulfia Allakhverdi , PhD FAAAAI
Zoulfia Allakhverdi , PhD FAAAAI
1401
Allied Health: Ask-the-Expert Question & Answer Roundtable Luncheon TICKETED
Session Details
Session Details
Friday, March 4, 2016: 12:30 PM-1:45 PM
Convention Center, Level Two, Room 410
1.25 CME/CE
Workshop
Moderator:
John D. Milewski , FACMPE, MSHA
Learning Objectives:
- Discuss billing, coding, ICD-10, PCMH for the allergist, staff training and collection strategies for high deductible plans
- Identify hot-topic subjects and address issues that arise in practice
1501
JACI: Year-in-Review TICKETED
Session Details
Session Details
Friday, March 4, 2016: 12:30 PM-1:45 PM
Convention Center, Level Two, Room 403A
1.25 CME/CE
Workshop
Moderator:
Cezmi A. Akdis , MD FAAAAI
Learning Objectives:
- Discuss and provide an update on the cutting edge literature on atopic dermatitis, food allergy, and asthma, in regards to pathogenesis, treatment and prevention
1502
Dilemmas in Asthma Management
Session Details
Session Details
Friday, March 4, 2016: 12:30 PM-1:45 PM
Convention Center, Level Two, Room 403B
1.25 CME/CE
Workshop - Panel Discussion
Moderator:
Caroline C. Horner , MD FAAAAI
Learning Objectives:
- Discuss clinical phenotypes of asthmatics with fungal sensitization, steroid resistant and work-exacerbated asthma
- Describe optimal management strategies for difficult asthma phenotypes
1503
ILC2: Gateway to Th2 Inflammation
Session Details
Session Details
Friday, March 4, 2016: 12:30 PM-1:45 PM
Convention Center, Level Two, Theatre (Room 411)
1.25 CME/CE
Workshop
Moderator:
David H. Broide , MB ChB FAAAAI
Learning Objectives:
- Discuss how ILC2 contributes in a substantial way to the induction of allergic skin diseases
- Describe ILC2 cells that have important regulatory roles in the balance between maintenance of normal gut homeostasis and establishment of inflammatory bowel disease
- Identify mechanisms by which ILC2 contributes to asthma pathogenesis
1504
SLIT Practical Considerations, Unmet Needs and FAQs
Session Details
Session Details
Friday, March 4, 2016: 12:30 PM-1:45 PM
Convention Center, Level Two, Room 503
1.25 CME/CE
Workshop - Panel Discussion
Moderator:
Bryan L. Martin , DO FAAAAI
Learning Objectives:
- Describe characteristics of the ideal patient for SCIT vs. SLIT incl. what to do with polysensitized patients
- Discuss safety and adherence issues concerning SLIT
- Discuss and contrast the off-label use of allergen extract solution for SLIT compared with FDA-approved sublingual tablets
1505
FPIES: What We Know, What We Don't Know and What We Still Need to Know TICKETED
Session Details
Session Details
Friday, March 4, 2016: 12:30 PM-1:45 PM
Convention Center, Level Two, Room 518
1.25 CME/CE
Workshop
Moderator:
Terri F. Brown-Whitehorn , MD
Learning Objectives:
- Discuss and appraise consensus guidelines for diagnosis and management of FPIES
- Describe nutritional management of FPIES
- Describe the unmet needs in FPIES, including epidemiology, pathophysiology and others
1506
The Safety of Asthma and Allergy Medications During Pregnancy: New Horizons
Session Details
Session Details
Friday, March 4, 2016: 12:30 PM-1:45 PM
Convention Center, Level Two, Room 409AB
1.25 CME/CE
Workshop
Moderator:
Michael Schatz , MD MS FAAAAI
Learning Objectives:
- Identify knowledge gaps regarding the safety of asthma and allergy medications during pregnancy
- Optimally use the information provided by the new FDA pregnancy labeling system for clinical decision making
- Appreciate the role of VAMPSS in providing new information for the pregnancy label and filling in knowledge gaps regarding the safety of asthma and allergy medications during pregnancy
12:45 PM-1:45 PM
1510
The Use of Social Media in the Allergy Practice TICKETED
Session Details
Session Details
Friday, March 4, 2016: 12:45 PM-1:45 PM
JW Marriott, Diamond Ballroom Level, Salon 3
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss how social media can be used to improve practice marketing
- Identify methods of improving patient communication
- Identify potential problems posed by using social media
1511
Barriers to Asthma Management in Schools TICKETED
Session Details
Session Details
Friday, March 4, 2016: 12:45 PM-1:45 PM
JW Marriott, Diamond Ballroom Level, Salon 7
1.00 CME/CE
Seminar
Learning Objectives:
- Describe components of an ideal school-based asthma program
- Identify barriers to program implementation
- Discuss and list new tools related to innovative implementation and training
1512
Whole Exome Sequencing: Guidance in Modalities and Interpretation for the Practicing Immunologist TICKETED
Session Details
Session Details
Friday, March 4, 2016: 12:45 PM-1:45 PM
JW Marriott, Diamond Ballroom Level, Salon 8
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss whole exome sequencing and how to utilize public databases
- Discuss specific examples including CVID and RAG deficiency and how whole genome sequecing approaches are being employed
1513
The Intricacy of Penicillin and Cephalosporin Allergy Evaluation TICKETED
Session Details
Session Details
Friday, March 4, 2016: 12:45 PM-1:45 PM
JW Marriott, Diamond Ballroom Level, Salon 9
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the different components of the penicillin skin test
- Discuss the evaluation and management of patients with other beta lactam allergies
- Discuss the role of oral challenges to penicillin and/or amoxicillin in the evaluation of penicillin allergy
1514
Non-IgE-Mediated Food Allergies TICKETED
Session Details
Session Details
Friday, March 4, 2016: 12:45 PM-1:45 PM
JW Marriott, Diamond Ballroom Level, Salon 10
1.00 CME/CE
Seminar
Learning Objectives:
- Identify clinical manifestation of non-IgE mediated food allergy such as FPIES, proctocolitis and enteropathy
- Describe approach to diagnosis
- Describe practical management
1551
Allied Health: Precautionary Allergen Labeling Contains Useful Information
Session Details
Session Details
Friday, March 4, 2016: 12:45 PM-1:45 PM
Convention Center, Level Two, Room 404AB
1.00 CME/CE
Pro/Con Debate
Moderator:
Scott H. Sicherer , MD FAAAAI
Learning Objectives:
- Identify how to interpret precautionary labels and provide appropriate education to families with food allergies
- Discuss how to interpret precautionary labels based on the avoidance needs of patients with IgE-mediated food allergies, FPIES and EoE
- Identify the research surrounding threshold levels and what these mean or may mean in terms of labeling for risk of cross contact in the U.S. and other countries
2:00 PM-3:30 PM
1601
The Origins of Childhood Asthma
Session Details
Session Details
Friday, March 4, 2016: 2:00 PM-3:30 PM
Convention Center, Level One, South Exhibit Hall G
1.50 CME/CE
Plenary
Moderator:
Robert F. Lemanske Jr. , MD FAAAAI
Learning Objectives:
- Describe the etiology of respiratory tract wheezing illnesses in preschool children that increase risk for the expression of during school age
- Discuss genetic risk pathways for the development of asthma during childhood
- Discuss the influence of microbial exposures in early life that modify the risk of developing childhood asthma
4:00 PM-5:15 PM
1801
What Can Implementation Research Teach Us About the Management of Asthma?
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level One, Petree Hall C
1.25 CME/CE
Symposium
Moderator:
Giselle Mosnaim , MD MS FAAAAI
Learning Objectives:
- Describe and define the role of implementation research to improvement of asthma outcomes
- Identify the methodologies for conducting implementation research in asthma
- Identify new areas for implementation research in asthma
1802
Management of Atopic Dermatitis: What's New?
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level One, Petree Hall D
1.25 CME/CE
Symposium
Moderator:
Kelly D. Stone , MD PhD FAAAAI
Learning Objectives:
- Discuss the role of skin microbiome in atopic dermatitis
- Discuss patient education for atopic dermatitis
- Discuss possible therapeutic consequences owing to new insights into the pathogenesis of atopic dermatitis
1803
Automating Pollen Identification/NAB
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 404AB
1.25 CME/CE
Symposium
Moderator:
Dennis K. Ledford , MD FAAAAI
Learning Objectives:
- Discuss current laboratory techniques which could permit automated aeroallergen determinations
- Review the problems associated with collecting samples for automated aeroallergen assessments
- Identify and provide an up-to-date scientific analysis of how soon such techniques will be available to the community
1804
B-Regulatory Cells: No Longer Playing Second Fiddle to T Regs
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Theatre (Room 411)
1.25 CME/CE
Symposium
Moderator:
Cezmi A. Akdis , MD FAAAAI
Learning Objectives:
- Discuss the prominent role B cells that express PD-L1 occupy in the regulation of humoral immune responses
- Describe the settings in which B lymphocytes express IL-10, providing these B cells with potent ability to regulate both innate and adaptive immune responses
- Discuss settings in which B lymphocytes may play important roles as modulators of all responses in organ transplantation
1805
Secondary Immune Deficiencies (Non-HIV)
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 408A
1.25 CME/CE
Symposium
Moderator:
Christina L. Nance , PhD
Learning Objectives:
- Discuss secondary immunodeficiency due to underlying disease states, environmental exposures and other causes
- Discuss underlying mechanisms and sequelae of the immune dysfunction of secondary immunodeficiencies
1806
Non-IgE-Mediated Gastrointestinal Food Allergies in Children and Adults
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 408B
1.25 CME/CE
Symposium
Moderator:
Kirsi M. Jarvinen-Seppo , MD PhD FAAAAI
Learning Objectives:
- Describe immune responses to foods in the GI tract
- Describe manifestations, diagnosis and management of food protein-induced enterocolitis syndrome (FPIES) with emphasis on the evolution of systemic IgE immune response to foods and implications for management
- Describe the continuum of immune responses to wheat from childhood to adulthood and potential therapeutic targets
1807
Allergy in Schools: Keeping Kids Healthy and Safe
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 502A
1.25 CME/CE
Symposium
Moderator:
Carla M. Davis , MD FAAAAI
Learning Objectives:
- Discuss and guide management of asthma in schools
- Discuss and guide management of anaphylaxis in schools
- Describe management of food allergy in schools
1808
Microbial Regulation of Allergic Airway Inflammation: Lessons from the AADCRC
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 502B
1.25 CME/CE
Symposium
Moderator:
R. Stokes Peebles Jr. , MD FAAAAI
Learning Objectives:
- Discuss and define the factors that regulate severity of illness to rhinovirus infection
- Identify the mechanisms by which CARDS toxin induces allergic airway inflammation
- Describe how virus infection regulates airway epithelial cell function
1810
Allied Health Plenary: Working Together to Improve Asthma Care
Session Details
Session Details
Friday, March 4, 2016: 4:00 PM-5:15 PM
Convention Center, Level Two, Room 515A
1.25 CME/CE
Other
Moderator:
Nina A. Zimmermann , MSN RN ANP-BC AE-C
Learning Objectives:
- Describe the role that health care providers can play in communication with patients, families and school personnel to improve asthma care
- Identify communication strategies for school staff to communicate information to providers to improve medication adherence and reduce school absences
4:45 PM-6:30 PM
Federation of RSLAAIS Assembly Forum, Business Meeting and Reception
Session Details
Session Details
Friday, March 4, 2016: 4:45 PM-6:30 PM
Convention Center, Level Two, Room 515B
0.00 CME/CE
5:00 PM-6:00 PM
FIT Reception
Session Details
Session Details
Friday, March 4, 2016: 5:00 PM-6:00 PM
JW Marriott, Diamond Ballroom Level, Salon 6 & 7
0.00 CME/CE
5:15 PM-6:15 PM
Annual Meeting Awards Committee
Session Details
Session Details
Friday, March 4, 2016: 5:15 PM-6:15 PM
JW Marriott, Third Floor, Atrium 2
0.00 CME/CE
Vaccines and Biological Threats Committee Meeting
Session Details
Session Details
Friday, March 4, 2016: 5:15 PM-6:15 PM
JW Marriott, Third Floor, Plaza 1
0.00 CME/CE
5:15 PM-6:30 PM
Primary Immunodeficiency Diseases Committee
Session Details
Session Details
Friday, March 4, 2016: 5:15 PM-6:30 PM
JW Marriott, Diamond Ballroom Level: Salon 1 & 2
0.00 CME/CE
5:30 PM-6:30 PM
NAB Counters Meeting
Session Details
Session Details
Friday, March 4, 2016: 5:30 PM-6:30 PM
JW Marriott, Diamond Ballroom Level, Salon 3
0.00 CME/CE
6:30 PM-8:30 PM
New Frontiers and Treatment Advances for ATOPIC DERMATITIS, ASTHMA, and RELATED IMMUNE-RELATED CONDITIONS
Session Details
Session Details
Friday, March 4, 2016: 6:30 PM-8:30 PM
JW Marriott, Platinum Ballroom Level, Salon E
0.00 CME/CE
Peanut Allergy Oral Immunotherapy: The Past, Present and a Look Into the Future
Session Details
Session Details
Friday, March 4, 2016: 6:30 PM-8:30 PM
JW Marriott, Platinum Ballroom Level, Salon FGHIJ
0.00 CME/CE
The Role of Eosinophils in the Management of Severe Asthma
Session Details
Session Details
Friday, March 4, 2016: 6:30 PM-8:30 PM
JW Marriott, Platinum Ballroom Level, Salon D
0.00 CME/CE
Two Sides to Every Story: Expert Insights and a Patient Perspective on a Subcutaneous Immune Globulin Infusion for Adult Patients with Primary Immunodeficiency
Session Details
Session Details
Friday, March 4, 2016: 6:30 PM-8:30 PM
JW Marriott, Platinum Ballroom Level, Salon ABC
0.00 CME/CE
8:30 PM-10:30 PM
Joint Presentation on Seasonal Allergic Rhinitis and Maintenance Treatment of Asthma
Session Details
Session Details
Friday, March 4, 2016: 8:30 PM-10:30 PM
JW Marriott, Diamond Ballroom Level, Salon 5
0.00 CME/CE
Saturday, March 5, 2016
6:30 AM-7:45 AM
JACI Editorial Board Meeting
Session Details
Session Details
Saturday, March 5, 2016: 6:30 AM-7:45 AM
Convention Center, Level One Concourse Hall Room 153AB
0.00 CME/CE
6:30 AM-8:00 AM
Adverse Reactions to Foods Committee
Session Details
Session Details
Saturday, March 5, 2016: 6:30 AM-8:00 AM
Convention Center, Level Two, Room 309
0.00 CME/CE
Immunotherapy, Allergen Standardization & Allergy Diagnostics Committee
Session Details
Session Details
Saturday, March 5, 2016: 6:30 AM-8:00 AM
Convention Center, Level One, Concourse Hall Room 150B
0.00 CME/CE
6:45 AM-7:45 AM
2001
Smoking Cessation in Asthmatics: Behavioral, Pharmacologic and E-Cigarette Modalities TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 1
1.00 CME/CE
Seminar
Learning Objectives:
- Describe the behavioral and pharmacologic options for smoking cessation
- Describe the safety and efficacy of e-cigarettes for smoking cessation
2002
Performing Outpatient Aspirin Desensitizations for Patients with AERD TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 2
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss how to apply aspirin desensitization protocols
- Discuss how to identify patients for outpatient desensitization
2003
Making Your EMR Work for You TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 3
1.00 CME/CE
Seminar
Learning Objectives:
- Identify problems encountered by practices when adopting an EHR
- Discuss how to overcome barriers
- Identify how the EHR can be harnessed to improve office efficiency
2004
The Link to Immunodeficiency: Targeted Treatment TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 6
1.00 CME/CE
Seminar
Learning Objectives:
- Describe impaired tolerance mechanisms among patients with autoimmunity and primary immunodeficiency
- Discuss current approach to treat autoimmune cytopenias, the most common autoimmune complications among patients with autoimmunity and primary immunodeficiencies
- Discuss targeted and innovative therapies for autoimmunity in certain immunodeficiencies
2005
How Allergen Extracts are Made: From Source Materials to Allergen Extracts TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 7
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the source materials and methods to manufacture fungal raw materials used to produce allergen extracts
- Describe the source materials and methods to manufacture insect and mammalian raw materials used to produce allergen extracts
- Discuss the source materials and methods to manufacture venom extracts
2006
Update in Occupational Allergy: Occupational Anaphylaxis TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 8
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the current scientific evidence linking exposure to occupational triggers and the risk of anaphylaxis
- Describe the state-of-the-art diagnosis of occupational anaphylaxis
- Identify possible preventive measures
2007
Early Barrier Therapy to Prevent and Treat Eczema TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 9
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss and evaluate the use of barrier therapy before eczema clinically appears
- Discuss the barrier therapy as secondary prevention
- Discuss different types of barrier creams and their applications
2008
Clinical Challenges in the Prevention of Food Allergy Through Early Introduction TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 10
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss and compare the evidence for early introduction of peanut versus other foods such as egg and milk in food allergy prevention in various infant populations
- Describe the approaches to practical implementation to early food introduction for at-risk infants
- Discuss if early introduction via maternal diet during pregnancy and lactation has a protective effect
2009
EoE: Dietary Pitfalls and Practical Management in Children and Adults: Are there Similarities at All? TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon A
1.00 CME/CE
Seminar
Learning Objectives:
- Describe the best practice in the management of multiple food avoidance in children and adults with EoE
- Identify the main foods involved in EoE
- Discuss practical tips on the dietary management of EoE in children and adults
2010
Legalization of Cannabis: Implications for the Allergy Care Provider TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon B
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the physiological effects of cannabis exposure to the respiratory system
- Identify the patterns of use of cannabis by adolescents
- Discuss how to approach and advise patients of all ages who use cannabis
2011
Mobile Asthma Care Challenges, Rewards and Reach TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon F
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss mobile asthma care delivery systems in underserved populations
- Discuss disease tracking systems for clinical outcome measures of asthma
2012
Drug Allergy Testing and Desensitization Protocols in Your Practice TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon G
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss drug allergy testing protocols
- Discuss desensitization protocols for the outpatient setting
- Discuss how to create desensitization protocols for the inpatient setting
2013
Prostaglandin Regulation of Allergic Diseases TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon H
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the effector and regulatory functions of PGE2 in allergic inflammation
- Discuss and appreciate how products of the different arms of the prostaglandin pathways govern distinct biological effects
2021
Allied Health: Treatment Options for the Young Wheezers TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon I
1.00 CME/CE
Seminar
Learning Objectives:
- Identify treatment of wheezing only with colds
- Discuss treatment of exacerbations in the mild persistent wheezer, inhaled corticosteroids and OCS- which one and how to give
- Identify the role of Azithromycin in young wheezers
2022
Allied Health: Cooking and Meal Time with Food Allergy TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon J
1.00 CME/CE
Seminar
Learning Objectives:
- Identify strategies for planning enjoyable and nutritious meals with a family member who has a food allergy
- Discuss preparation of safe meals at home including prevention of cross contamination
A/I Division Directors Committee Meeting
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Third Floor, Plaza 1
0.00 CME/CE
Fellows-In-Training Committee
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
Convention Center, Level One, Concourse Hall Room 150C
0.00 CME/CE
Measures Stewardship Committee
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
Convention Center, Level One, Concourse Hall Room 150A
0.00 CME/CE
Sports, Exercise and Fitness Committee Meeting
Session Details
Session Details
Saturday, March 5, 2016: 6:45 AM-7:45 AM
JW Marriott, Third Floor, Olympic 1
0.00 CME/CE
7:45 AM-9:00 AM
2051
Allied Health: With the Changing Market Place of High Deductible Plans How are Clinics Addressing Their Collection Processed to Keep Current with the Trends of the Marketplace?
Session Details
Session Details
Saturday, March 5, 2016: 7:45 AM-9:00 AM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Workshop
Moderator:
John D. Milewski , FACMPE, MSHA
Learning Objectives:
- Discuss a process of storing patient credit cards and collecting the information at the time of service or appointment scheduling
- Describe how to communicate with patients about collecting payment in advance
- Describe how technology in payment collection can be of value
8:15 AM-9:45 AM
2101
Immunoglobulin E: The First 50 Years and Beyond
Session Details
Session Details
Saturday, March 5, 2016: 8:15 AM-9:45 AM
Convention Center, Level One, South Exhibit Hall G
1.50 CME/CE
Plenary
Moderator:
K. Frank Austen , MD FAAAAI
Learning Objectives:
- Describe the historic aspects and key scientists involved in discovery of IgE
- Discuss the role of IgE in pathogenesis and diagnosis of allergic disease, and mechanisms of its regulation of production
- Identify the disorders that can be successfully treated by targeting allergen specific IgE
9:15 AM-10:30 AM
2151
Allied Health: PQRS Compliance in the Allergy Office
Session Details
Session Details
Saturday, March 5, 2016: 9:15 AM-10:30 AM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Workshop
Moderator:
John D. Milewski , FACMPE, MSHA
Learning Objectives:
- Discuss how to meet allergy compliance measures
- Identify the timelines and reporting options
- Discuss what we know about PQRS audits, appeals and the PQRS Wizard as a tool
9:45 AM-10:45 AM
2201
Asthma Epidemiology
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Psychosocial Associations with Life-Threatening Asthma in Inner City Children
Mary E. Bollinger, DO FAAAAI Arlene Butz, ScD,CRNP Cassie Lewis-Land, MS Tricia Morphew, MSc
Mary E. Bollinger, DO FAAAAI Arlene Butz, ScD,CRNP Cassie Lewis-Land, MS Tricia Morphew, MSc
Prevalence of Asthma-Chronic Obstructive Pulmonary Disease (COPD) Overlap Syndrome in Brazilian Elderly Patients
Tamara A de Freitas Antonio Godinho Netto Beatriz Aarestrup Fernando M. Aarestrup, MD, PhD
Tamara A de Freitas Antonio Godinho Netto Beatriz Aarestrup Fernando M. Aarestrup, MD, PhD
Negative Skin Prick Test Predicts Asthma Remission in Preschool Children
Noppasorn Sitthisarunkul, MD Pasuree Sangsupawanich, MD, PhD Wanaporn Anuntaseree, MD
Noppasorn Sitthisarunkul, MD Pasuree Sangsupawanich, MD, PhD Wanaporn Anuntaseree, MD
Early Diagnosis of Asthma and Allergies Among Wroclaw Children
Andrzej M. Fal Dorota Kiedik Agnieszka Muszynska Iwona Pirogowicz
Andrzej M. Fal Dorota Kiedik Agnieszka Muszynska Iwona Pirogowicz
Spice Allergy: Asthma in the Food Industry.
Mariangelica Bermudez Martinez Ricardo Moreno-Borque Paula Sanchez-Lopez Pilar Gajate- Fernandez
Mariangelica Bermudez Martinez Ricardo Moreno-Borque Paula Sanchez-Lopez Pilar Gajate- Fernandez
The Association with Exercise Capacity and Anemia in Chronic Airway Disease
Hyun Jung Jin, MD Jin Hong Chung
Hyun Jung Jin, MD Jin Hong Chung
Retrospective Analysis of Allergy Skin Testing Results and Relationship to Asthma in the Tucson Adult Population
Ryan Buckley, MD Snehal Patel, DO Tara F. Carr, MD
Ryan Buckley, MD Snehal Patel, DO Tara F. Carr, MD
Persisting Long Term Benefits of Smoking Abstinence and Reduction in Asthmatic Smokers Who Have Switched to Electronic Cigarettes
Davide Campagna, MD Jaymin B. Morjaria Pasquale Caponnetto Massimo Caruso, PhD, FIT AAAAI Maria Domenica Amaradio Giovanni Ciampi Cristina Russo, MD Riccardo Polosa, MD PhD FAAAAI
Davide Campagna, MD Jaymin B. Morjaria Pasquale Caponnetto Massimo Caruso, PhD, FIT AAAAI Maria Domenica Amaradio Giovanni Ciampi Cristina Russo, MD Riccardo Polosa, MD PhD FAAAAI
Cost and Healthcare Utilization in Asthma Patients with High Oral Corticosteroid Use
Karina Raimundo, BPharm, MS Ka M Ngai, MD, MPH Eunice Chang, PhD Michael Broder, MD, MSHS Noelle M. Griffin, PhD
Karina Raimundo, BPharm, MS Ka M Ngai, MD, MPH Eunice Chang, PhD Michael Broder, MD, MSHS Noelle M. Griffin, PhD
Lung Function, Allergic Sensitization and Respiratory Symptoms Among Children and Adolescents with Sickle Cell Disease
Gustavo Wandalsen, MD Maíra Moya Carolina Cobra Cíntia Jonhston Josefina Braga Dirceu Sole, MD PhD FAAAAI Fernanda C Lanza Andrea Angel
Gustavo Wandalsen, MD Maíra Moya Carolina Cobra Cíntia Jonhston Josefina Braga Dirceu Sole, MD PhD FAAAAI Fernanda C Lanza Andrea Angel
Risk of Developing Rheumatoid Arthritis in Adults with Asthma: A Population-Based Case-Control Study
Mary C Rolfes Youn Ho Shin, MD Chung I. Wi, MD Cynthia S Crowson, MS Richard S Pendegraft Euijung Ryu, PhD Young J. Juhn, MD MPH
Mary C Rolfes Youn Ho Shin, MD Chung I. Wi, MD Cynthia S Crowson, MS Richard S Pendegraft Euijung Ryu, PhD Young J. Juhn, MD MPH
Treatment Patterns of Recurrent Wheezing in Infants: Two Surveys Separated By Seven Years
Herberto J. Chong Neto, MD PhD FAAAAI Nelson A. Rosario, MD PhD FAAAAI Dirceu Sole, MD PhD FAAAAI Javier Mallol, MD, PhD
Herberto J. Chong Neto, MD PhD FAAAAI Nelson A. Rosario, MD PhD FAAAAI Dirceu Sole, MD PhD FAAAAI Javier Mallol, MD, PhD
The Association Between Pollutant Levels and Asthma-Related Emergency Department Visits in the Bronx after the World Trade Center Attacks
Kunwar Ishan Sharma Jennifer Toh, MD Tulsi Desai Mili Shum, MD Priyank Patel David L. Rosenstreich, MD FAAAAI Sunit P. Jariwala, MD
Kunwar Ishan Sharma Jennifer Toh, MD Tulsi Desai Mili Shum, MD Priyank Patel David L. Rosenstreich, MD FAAAAI Sunit P. Jariwala, MD
An Analysis of Obesity and Asthma Morbidity in Patients Managed at the Children's Hospital at Montefiore's Asthma Center.
Gary K. Soffer, MD Jennifer Toh, MD Sunit P. Jariwala, MD Deepa Rastogi, MD
Gary K. Soffer, MD Jennifer Toh, MD Sunit P. Jariwala, MD Deepa Rastogi, MD
Predicting Factors for Asthma Remission in Children
Natcha Siripattarasopon, MD Punchama Pacharn, MD Orathai Jirapongsananuruk, MD Nualanong Visitsunthorn, MD Pakit Vichyanond, MD FAAAAI Jittima Veskitkul, MD
Natcha Siripattarasopon, MD Punchama Pacharn, MD Orathai Jirapongsananuruk, MD Nualanong Visitsunthorn, MD Pakit Vichyanond, MD FAAAAI Jittima Veskitkul, MD
Risk Factors for Asthma at Age 7 to 8 in Early Childhood Wheezers: Results from a Japanese Asthma Cohort Study
Mayumi Furukawa, MD Mari Sasaki, MD Hiroko Watanabe, MD Koichi Yoshida, MD Takao Fujisawa, MD PhD FAAAAI Motohiro Ebisawa, MD PhD FAAAAI Hiroshi Odajima, MD, PhD Akira Akasawa, MD, PhD
Mayumi Furukawa, MD Mari Sasaki, MD Hiroko Watanabe, MD Koichi Yoshida, MD Takao Fujisawa, MD PhD FAAAAI Motohiro Ebisawa, MD PhD FAAAAI Hiroshi Odajima, MD, PhD Akira Akasawa, MD, PhD
Impact of Asthma Exacerbations on Health Status in Patients with Severe Asthma
Sarah Cockle Linda Nelsen Miriam Kimel Frank C. Albers, M.D., Ph.D. Paul Jones
Sarah Cockle Linda Nelsen Miriam Kimel Frank C. Albers, M.D., Ph.D. Paul Jones
Persistence of Airflow Obstruction in Asthmatic Children
Lori Banka, DO Yang Lu, PhD Lyne G. Scott, MD FAAAAI Salima A. Thobani, M.D. Marilyn Li, M.D. Cindy Xi, MD Kenny Y. Kwong
Lori Banka, DO Yang Lu, PhD Lyne G. Scott, MD FAAAAI Salima A. Thobani, M.D. Marilyn Li, M.D. Cindy Xi, MD Kenny Y. Kwong
Characteristics That Distinguish Difficult-to-Control Asthma in Inner-City Children
Jacqueline A. Pongracic, MD FAAAAI Rebecca A. Zabel, MS Denise C. Babineau, PhD Edward M. Zoratti, MD, FAAAAI George T. O'Connor, MD Robert A. Wood, MD FAAAAI Gurjit K. Khurana Hershey, MD PhD FAAAAI Carolyn Kercsmar, MD Rebecca S. Gruchalla, MD PhD FAAAAI Meyer Kattan, MD Stephen J. Teach, MD Samuel J. Arbes Jr. William W. Busse, MD FAAAAI Peter J. Gergen, MD MPH Alkis Togias, MD FAAAAI Cynthia Visness, PhD MPH Andrew H Liu, MD FAAAAI
Jacqueline A. Pongracic, MD FAAAAI Rebecca A. Zabel, MS Denise C. Babineau, PhD Edward M. Zoratti, MD, FAAAAI George T. O'Connor, MD Robert A. Wood, MD FAAAAI Gurjit K. Khurana Hershey, MD PhD FAAAAI Carolyn Kercsmar, MD Rebecca S. Gruchalla, MD PhD FAAAAI Meyer Kattan, MD Stephen J. Teach, MD Samuel J. Arbes Jr. William W. Busse, MD FAAAAI Peter J. Gergen, MD MPH Alkis Togias, MD FAAAAI Cynthia Visness, PhD MPH Andrew H Liu, MD FAAAAI
Income Is an Independent Risk Factor for Worse Asthma Outcomes
Juan Carlos Cardet, MD Tonya S. King Margee Louisias, MD Mario Castro, MD MPH Christopher D. Codispoti, MD PhD Ryan Dunn, MD Brenda L. Giles, MD Fernando Holguin, MD MPH John Lima, MD Dayna Long, MD Njira Lugogo, MD Sharmilee M. Nyenhuis, MD FAAAAI Victor E. Ortega, MD Sima Ramratnam, MD Michael E. Wechsler, MD MMSc Elliot Israel, MD FAAAAI Wanda Phipatanakul, MD MS FAAAAI
Juan Carlos Cardet, MD Tonya S. King Margee Louisias, MD Mario Castro, MD MPH Christopher D. Codispoti, MD PhD Ryan Dunn, MD Brenda L. Giles, MD Fernando Holguin, MD MPH John Lima, MD Dayna Long, MD Njira Lugogo, MD Sharmilee M. Nyenhuis, MD FAAAAI Victor E. Ortega, MD Sima Ramratnam, MD Michael E. Wechsler, MD MMSc Elliot Israel, MD FAAAAI Wanda Phipatanakul, MD MS FAAAAI
Higher Immunoglobulin E (IgE) Levels Are Associated with Greater Emergency Care and Other Healthcare Utilization Among Asthma Patients in a Real-World Data Setting
Allan T. Luskin, MD Evgeniya Antonova, MS, PhD Michael Broder, MD, MSHS Eunice Chang, PhD Theodore A. Omachi, MD, MBA
Allan T. Luskin, MD Evgeniya Antonova, MS, PhD Michael Broder, MD, MSHS Eunice Chang, PhD Theodore A. Omachi, MD, MBA
Impact of a Mobile Health and Sensor-Driven Asthma Management Pilot Study on Symptoms, Control, and Self-Management
David Van Sickle, PhD Meredith Barrett, PhD Olivier Humblet, Sc.D. Jason Su, PhD Kelly Henderson Ted Smith, PhD
David Van Sickle, PhD Meredith Barrett, PhD Olivier Humblet, Sc.D. Jason Su, PhD Kelly Henderson Ted Smith, PhD
Is Unrecognized Food Allergy or Aeroallergen Sensitization Responsible for Emergency Department Visits Attributed to Asthma?
Jennifer Dantzer, MD Torie Grant, MD Elizabeth Matsui, MD MHS Corinne Keet, MD PhD
Jennifer Dantzer, MD Torie Grant, MD Elizabeth Matsui, MD MHS Corinne Keet, MD PhD
Insulin Resistance Modifies the Association Between Obesity and Current Asthma in Adults
Samuel Y Ash, MD Juan Carlos Cardet, MD Tope Kusa, MBBS, MPH Carlos Camargo Jr., MD, DrPH Elliot Israel, MD FAAAAI
Samuel Y Ash, MD Juan Carlos Cardet, MD Tope Kusa, MBBS, MPH Carlos Camargo Jr., MD, DrPH Elliot Israel, MD FAAAAI
Identification of Pathways to Asthma Severity in Inner-City Children
Andrew H Liu, MD FAAAAI Denise C. Babineau, PhD Rebecca A. Zabel, MS Edward M. Zoratti, MD, FAAAAI Jacqueline A. Pongracic, MD FAAAAI George T. O'Connor, MD Robert A. Wood, MD FAAAAI Gurjit K. Khurana Hershey, MD PhD FAAAAI Carolyn Kercsmar, MD Rebecca S. Gruchalla, MD PhD FAAAAI Meyer Kattan, MD Stephen J. Teach, MD Samuel J. Arbes Jr. Peter J. Gergen, MD MPH Alkis Togias, MD FAAAAI Cynthia Visness, PhD MPH William W. Busse, MD FAAAAI
Andrew H Liu, MD FAAAAI Denise C. Babineau, PhD Rebecca A. Zabel, MS Edward M. Zoratti, MD, FAAAAI Jacqueline A. Pongracic, MD FAAAAI George T. O'Connor, MD Robert A. Wood, MD FAAAAI Gurjit K. Khurana Hershey, MD PhD FAAAAI Carolyn Kercsmar, MD Rebecca S. Gruchalla, MD PhD FAAAAI Meyer Kattan, MD Stephen J. Teach, MD Samuel J. Arbes Jr. Peter J. Gergen, MD MPH Alkis Togias, MD FAAAAI Cynthia Visness, PhD MPH William W. Busse, MD FAAAAI
Association Between Asthma Symptom Scores and Increased Perceived Stress and Trait Anxiety in Asthmatic Adolescents
Cathryn J. Luria, MD Alexandra R. Sitarik, M.S. Suzanne Havstad, M.A. Ganesa R Wegienka, PhD Haejin Kim, MD Edward M. Zoratti, MD, FAAAAI Christine L.M. Joseph, PhD Andrea Cassidy-Bushrow, PhD
Cathryn J. Luria, MD Alexandra R. Sitarik, M.S. Suzanne Havstad, M.A. Ganesa R Wegienka, PhD Haejin Kim, MD Edward M. Zoratti, MD, FAAAAI Christine L.M. Joseph, PhD Andrea Cassidy-Bushrow, PhD
Risk Factors Associated with Asthma-Related Hospitalizations Among Older Adults
Joy Hsu, MD, MSCI Jessica Chen, BA Maria C Mirabelli, PhD
Joy Hsu, MD, MSCI Jessica Chen, BA Maria C Mirabelli, PhD
Influence of Depression on Asthma Outcomes in Older Adults – Results from the National Health and Nutrition Examination Survey (2007-2012)
Pooja M. Oza, MD Minal R. Patel, PhD MPH Alan P. Baptist, MD MPH FAAAAI
Pooja M. Oza, MD Minal R. Patel, PhD MPH Alan P. Baptist, MD MPH FAAAAI
2202
Asthma Therapy I: Biologics
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Retrospective Observational Study to Evaluate Long-Term Effectiveness and Safety of Omalizumab Treatment in Real-Life Setting in Allergy Centre of Spain
Dorkas Margarita Marquez Hernandez Jose A Bastidas Lys Herraez Elena Mederos A. Enriquez Matas, MD Ruth Mielgo Ballesteros, MD Consuelo Fernandez
Dorkas Margarita Marquez Hernandez Jose A Bastidas Lys Herraez Elena Mederos A. Enriquez Matas, MD Ruth Mielgo Ballesteros, MD Consuelo Fernandez
Efficacious Use of Omalizumab in the Treatment of Cystic Fibrosis
Diana Pham Hoang Pham, MD 2016, BSc, BA Ena Gaudet, RN Shawn Aaron, MD Stephanie Santucci, RN William H. Yang, MD
Diana Pham Hoang Pham, MD 2016, BSc, BA Ena Gaudet, RN Shawn Aaron, MD Stephanie Santucci, RN William H. Yang, MD
Effectiveness of Omalizumab in Asthmatics with Baseline Serum IgE>1500 IU/Ml Using a Novel Method for Assessing Response: Reality Study
Joseph D. Diaz, MD Jay Peters, MD Yogeet Kaur, MS Harjinder Singh, MD
Joseph D. Diaz, MD Jay Peters, MD Yogeet Kaur, MS Harjinder Singh, MD
Impact of Visit Compliance on Response to Omalizumab Therapy in a Real-Life Clinical Setting: Reality Study
Harjinder Singh, MD Jay Peters, MD Yogeet Kaur, MS Joseph D. Diaz, MD
Harjinder Singh, MD Jay Peters, MD Yogeet Kaur, MS Joseph D. Diaz, MD
Omalizumab Can be Effective in Patients with Allergic Bronchopulmonary Aspergillosis
John W. O'Quinn, MD Diana Pham Hoang Pham, MD 2016, BSc, BA Gonzalo G. Alvarez, MD Istvan T. Bencze, MD Krishna B. Sharma, MD Mark Smith, MD Shawn Aaron, MD Jennifer Block, MD Tara Keays, MD Judith Leech, MD David Schneidermen, MD Jodi Cameron, RPN Jennifer Forgie, RN Alicia Ring, RPN Stephanie Santucci, RN William H. Yang, MD
John W. O'Quinn, MD Diana Pham Hoang Pham, MD 2016, BSc, BA Gonzalo G. Alvarez, MD Istvan T. Bencze, MD Krishna B. Sharma, MD Mark Smith, MD Shawn Aaron, MD Jennifer Block, MD Tara Keays, MD Judith Leech, MD David Schneidermen, MD Jodi Cameron, RPN Jennifer Forgie, RN Alicia Ring, RPN Stephanie Santucci, RN William H. Yang, MD
Rapid Lung Function Improvement with Lebrikizumab in Patients with Uncontrolled Asthma
Jonathan Corren, MD Nicola A. Hanania, MD Phillip E. Korenblat, MD, FAAAAI Julie K. Olssen, MD, MS Nikhil Kamath, MD Sarah Gray, PhD Nicolas Martin Cecile T.J. Holweg, PhD John G. Matthews, MB, BS, MRSCP, PhD Susan L. Limb, MD Stephan Korom
Jonathan Corren, MD Nicola A. Hanania, MD Phillip E. Korenblat, MD, FAAAAI Julie K. Olssen, MD, MS Nikhil Kamath, MD Sarah Gray, PhD Nicolas Martin Cecile T.J. Holweg, PhD John G. Matthews, MB, BS, MRSCP, PhD Susan L. Limb, MD Stephan Korom
Biomarkers Associated with Response in Patients Initiating Omalizumab: Baseline Levels Among Patients in the Prospective Observational Study to Evaluate Predictors of Clinical Effectiveness in Response to Omalizumab (PROSPERO) Study
Bradley E. Chipps, MD FAAAAI William W. Busse, MD FAAAAI Allan T. Luskin, MD Robert S. Zeiger, MD PhD FAAAAI Benjamin Trzaskoma, MS Hooman Pazwash Theodore A. Omachi, MD, MBA Thomas B. Casale, MD FAAAAI
Bradley E. Chipps, MD FAAAAI William W. Busse, MD FAAAAI Allan T. Luskin, MD Robert S. Zeiger, MD PhD FAAAAI Benjamin Trzaskoma, MS Hooman Pazwash Theodore A. Omachi, MD, MBA Thomas B. Casale, MD FAAAAI
Poor Asthma Control Is Associated with Overall Daily Activity Impairment: 3-Year Data from the EXCELS Study of Omalizumab
Evgeniya Antonova, MS, PhD Benjamin Trzaskoma, MS Theodore A. Omachi, MD, MBA Michael Schatz, MD MS FAAAAI
Evgeniya Antonova, MS, PhD Benjamin Trzaskoma, MS Theodore A. Omachi, MD, MBA Michael Schatz, MD MS FAAAAI
Long-Term Safety and Efficacy of Mepolizumab in Patients with Severe Eosinophilic Asthma
Frank C. Albers, M.D., Ph.D. Njira Lugogo Martyn J Gilson Robert Price Steven W Yancey
Frank C. Albers, M.D., Ph.D. Njira Lugogo Martyn J Gilson Robert Price Steven W Yancey
Improvements in Asthma Quality of Life Questionnaire (AQLQ) Domains with Reslizumab in Patients with Inadequately Controlled Asthma and Elevated Blood Eosinophils
Jorge Maspero Joshua Jacobs Margaret Garin
Jorge Maspero Joshua Jacobs Margaret Garin
Interleukin-15 Overexpression Protect Mice from the Allergen-Induced Airway Obstruction
Sathisha Upparahalli Venkateshaiah, PhD Murli Manohar Chandrashekara Puthanapura Mahadevappa, PhD Anil Mishra, PhD FAAAAI
Sathisha Upparahalli Venkateshaiah, PhD Murli Manohar Chandrashekara Puthanapura Mahadevappa, PhD Anil Mishra, PhD FAAAAI
The Extent of Serum Periostin Reduction in Asthma Patients Treated with Lebrikizumab Is Related to Baseline Periostin Levels: A Pooled Analysis of Phase II Studies
David F Choy Cecile T.J. Holweg, PhD Fang Cai Joseph R. Arron John G. Matthews, MB, BS, MRSCP, PhD Heleen Scheerens, PhD
David F Choy Cecile T.J. Holweg, PhD Fang Cai Joseph R. Arron John G. Matthews, MB, BS, MRSCP, PhD Heleen Scheerens, PhD
Response to Omalizumab Therapy Based on Level of IgE: A Two Year Observational Study (REALITY Study)
Jay Peters, MD Harjinder Singh, MD Yogeet Kaur, MS Joseph D. Diaz, MD
Jay Peters, MD Harjinder Singh, MD Yogeet Kaur, MS Joseph D. Diaz, MD
Blood Eosinophils and Serum IgE Predict Response to Omalizumab in Patients with Severe Allergic Asthma: Innovate Trial Post-Hoc Analysis
Volkan Manga, MD Marc Humbert, MD PhD Ratko Djukanovic Steve Greenberg, MD Theodore A. Omachi, MD, MBA Benjamin Trzaskoma, MS Roland Buhl
Volkan Manga, MD Marc Humbert, MD PhD Ratko Djukanovic Steve Greenberg, MD Theodore A. Omachi, MD, MBA Benjamin Trzaskoma, MS Roland Buhl
Steroid Sparing Response with Mepolizumab: Durability of Steroid Reduction in Severe Asthma
Charlene M. Prazma, PhD Elisabeth H. Bel, MD PhD Neil C Barnes, MD Robert Price Frank C Albers Steven W Yancey
Charlene M. Prazma, PhD Elisabeth H. Bel, MD PhD Neil C Barnes, MD Robert Price Frank C Albers Steven W Yancey
Omalizumab and Severe Alergic Asthma : Assessment after 1 Year of Treatment
Rita Aguiar, MD Ana M. Mendes, MD Ana Célia Costa, MSc Fatima Duarte, MD Estrella Alonso Anabela Lopes, MD Elisa Pedro, MD Manuel Pereira-Barbosa
Rita Aguiar, MD Ana M. Mendes, MD Ana Célia Costa, MSc Fatima Duarte, MD Estrella Alonso Anabela Lopes, MD Elisa Pedro, MD Manuel Pereira-Barbosa
2203
Common Variable Immunodeficiency (CVID) and Other Hypogammaglobulinemia
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Use of Rituximab in Late Onset Leaky SCID
Diana X. Nichols-Vinueza, MD Hung S Luu, MD Norberto Rodriguez Baez, MD Yadira Rivera-Sanchez, MD Kenneth S Chen, MD Lee-Jun Wong, Ph.D Hui Yu, Ph.D M. Teresa De La Morena, MD
Diana X. Nichols-Vinueza, MD Hung S Luu, MD Norberto Rodriguez Baez, MD Yadira Rivera-Sanchez, MD Kenneth S Chen, MD Lee-Jun Wong, Ph.D Hui Yu, Ph.D M. Teresa De La Morena, MD
Anti-GAD65 Positive Stiff-Person Syndrome: Novel Association with Common Variable Immune Deficiency
Jack G. Ghably, MD Mark Guido, MD Sara Atwater, MD Guha Krishnaswamy, MD, FAAAI, CC-D, ABIHM
Jack G. Ghably, MD Mark Guido, MD Sara Atwater, MD Guha Krishnaswamy, MD, FAAAI, CC-D, ABIHM
The Effect of Immunoglobulin Levels on CVID Enteropathy Pathogenesis and Clinical Severity
Meng Chen, MD Edith Schussler, MD Mabel Ko, MD Paul J. Maglione, M.D., Ph.D. Charlotte Cunningham-Rundles, M.D., Ph.D.
Meng Chen, MD Edith Schussler, MD Mabel Ko, MD Paul J. Maglione, M.D., Ph.D. Charlotte Cunningham-Rundles, M.D., Ph.D.
An Older Gentleman with Common Variable Immunodeficiency (CVID): A Question of Primary Immunodeficiency Versus Secondary Belimumab-Induced Immunodeficiency
Amy B Schiffman, MD Laurianne G. Wild, MD FAAAAI
Amy B Schiffman, MD Laurianne G. Wild, MD FAAAAI
31 Year Old Caucasian Male Presenting with Hypogammoglobulinemia and T/B-Cell Lymphopenia
Nicholas L. Hartog, MD John Chrisinger, MD H. James Wedner, MD FAAAAI
Nicholas L. Hartog, MD John Chrisinger, MD H. James Wedner, MD FAAAAI
A Case of Concurrent Hypogammaglobulinemia, Cancer, and Cardiomyopathy: A Beta-Catenin Connection?
Camellia Hernandez, MD Cecilia Mikita, MD MPH FAAAAI
Camellia Hernandez, MD Cecilia Mikita, MD MPH FAAAAI
Three Cases of Elevated IL-1beta in Common Variable Immunodeficiency (CVID) with Autoimmune Complications
Jennifer Toh, MD Tatyana Gavrilova, MD Arye Rubinstein, MD, FAAAAI
Jennifer Toh, MD Tatyana Gavrilova, MD Arye Rubinstein, MD, FAAAAI
Quality over Quantity: A New Approach to Diagnose Specific Antibody Deficiency Using a Complement Fixation Assay
Charles A. Filion, MD, FRCPC Paul J. Maglione, M.D., Ph.D. Lin Radigan Charlotte Cunningham-Rundles, M.D., Ph.D.
Charles A. Filion, MD, FRCPC Paul J. Maglione, M.D., Ph.D. Lin Radigan Charlotte Cunningham-Rundles, M.D., Ph.D.
Common Variable Immunodeficiency in Two Adult Patients Diagnosed after Lymphoma As First Presentation.
Maria G Kanariou Sofia Tantou Marianna Tzanoudaki Marina Siakantari Angelos Pefanis
Maria G Kanariou Sofia Tantou Marianna Tzanoudaki Marina Siakantari Angelos Pefanis
T Cell Abnormalities in Patients with Common Variable Immunodeficiency
Adrian M Kahn, MD FAAAAI Gabriela Luque Gerardo M Gatti Brenda Ricchi Juan J Garcia Eduardo Cuestas Ana L Basquiera Virginia E Rivero
Adrian M Kahn, MD FAAAAI Gabriela Luque Gerardo M Gatti Brenda Ricchi Juan J Garcia Eduardo Cuestas Ana L Basquiera Virginia E Rivero
Recurrent Septic Arthritis with CVID and MGUS: A Chicken and Egg Conundrum
Evan M. Atkinson, MD Prathyusha Savjani, MD Laurianne G. Wild, MD FAAAAI
Evan M. Atkinson, MD Prathyusha Savjani, MD Laurianne G. Wild, MD FAAAAI
Neurologic Complications of Common Variable Immunodeficiency: A Case Report and Review of the Literature
Jenna T. Nguyen, MD Katherine E. Gundling, MD
Jenna T. Nguyen, MD Katherine E. Gundling, MD
A Case of Inflammatory Bowel Disease and Common Variable Immunodeficiency.
Shahab Virani, MD Praveen Govender, MD
Shahab Virani, MD Praveen Govender, MD
Two New Mutations in TACI Identified to be Causing Disease in Patients with Common Variable Immunodeficiency
Roula Daher, MD Elizabeth A. Secord, MD FAAAAI Pavadee Poowuttikul, MD
Roula Daher, MD Elizabeth A. Secord, MD FAAAAI Pavadee Poowuttikul, MD
Relationship of Specific IgM Responses with Infection and Lymphoproliferative Disease in Common Variable Immunodeficiency.
Tukisa D. Smith, M.D., M.S. Paul J. Maglione, M.D., Ph.D. Charlotte Cunningham-Rundles, M.D., Ph.D.
Tukisa D. Smith, M.D., M.S. Paul J. Maglione, M.D., Ph.D. Charlotte Cunningham-Rundles, M.D., Ph.D.
Treatment with Azathioprine and Rituximab in a Pediatric Patient with CVID and Granulomatous Liver Disease
Tammy Peng, MD Laura Wozniak Bita V Naini Maria Garcia-Lloret, MD, FAAAAI
Tammy Peng, MD Laura Wozniak Bita V Naini Maria Garcia-Lloret, MD, FAAAAI
Adult-Diagnosed Chronic Granulomatous Disease
Derek M. Smith, MD Charles N. Webb, MD G. William Palmer, MD FAAAAI
Derek M. Smith, MD Charles N. Webb, MD G. William Palmer, MD FAAAAI
Abnormal Newborn SCID Screen and Lymphopenia in an Infant Exposed to in Utero Folfirinox Chemotherapy
Daniel H Petroni, MD PhD Kathey Mohan, ARNP Andrew Coveler, MD Troy R. Torgerson, MD PhD Suzanne Skoda-Smith, MD
Daniel H Petroni, MD PhD Kathey Mohan, ARNP Andrew Coveler, MD Troy R. Torgerson, MD PhD Suzanne Skoda-Smith, MD
A Case of Acquired C1 Esterase Inhibitor (C1-INH) Deficiency As the Presenting Manifestation of Common Variable Immune Deficiency (CVID)
Andrew Parker, MD David Hagin, MD Summer E. Monforte, MD Andrew G. Ayars, MD Matthew C. Altman, MD
Andrew Parker, MD David Hagin, MD Summer E. Monforte, MD Andrew G. Ayars, MD Matthew C. Altman, MD
2204
Advancement in Allergic Diseases
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Cinnamon-Induced Contact Stomatitis: A Propos of Two Cases
Ekaterini I. Syrigou, PhD Photis Psarros Maria Zande Nikolaos K Syrigos Maria Vasiliou Athanasios Sinaniotis Konstantinos Syrigos
Ekaterini I. Syrigou, PhD Photis Psarros Maria Zande Nikolaos K Syrigos Maria Vasiliou Athanasios Sinaniotis Konstantinos Syrigos
Molecular Reference Materials for Standardization of Allergen Measurements
Sabina Wünschmann, PhD Kristie N Prtorich Cathy Minichino Heaven Cerritos Lisa D. Vailes Martin D. Chapman, PhD FAAAAI
Sabina Wünschmann, PhD Kristie N Prtorich Cathy Minichino Heaven Cerritos Lisa D. Vailes Martin D. Chapman, PhD FAAAAI
A Study of Immunogenetic Associations with Peanut Allergy Utilizing a Novel DNA Repository
Jonathan A. Hemler, MD Elizabeth S. Marston, MD Jason H. Karnes, PhD Andrew M. Glazer, PhD Elizabeth J. Phillips, MD Simon A. Mallal, MBBS Peggy L. Kendall, MD
Jonathan A. Hemler, MD Elizabeth S. Marston, MD Jason H. Karnes, PhD Andrew M. Glazer, PhD Elizabeth J. Phillips, MD Simon A. Mallal, MBBS Peggy L. Kendall, MD
The Role of Human Dendritic Cells in Cutaneous Allergen Recognition and Immune Activation
Anna R. Wolfson, MD Caroline L. Sokol, MD PhD Andrew D. Luster, MD PhD
Anna R. Wolfson, MD Caroline L. Sokol, MD PhD Andrew D. Luster, MD PhD
Tacrolimus: A Heart Pill to Swallow
Tara V. Saco, M.D. Dennis K. Ledford, MD FAAAAI Sweta Shah, M.D. Elimarys Perez-Colon, M.D. Lacey Harrington, MS-IV
Tara V. Saco, M.D. Dennis K. Ledford, MD FAAAAI Sweta Shah, M.D. Elimarys Perez-Colon, M.D. Lacey Harrington, MS-IV
Averting Danger: A Case of Anaphylaxis to Rabavert®
Sarah W. Spriet, DO Taylor A. Banks, MD Cecilia Mikita, MD MPH FAAAAI
Sarah W. Spriet, DO Taylor A. Banks, MD Cecilia Mikita, MD MPH FAAAAI
Reduction in Corticosteroid Use Among Patients Receiving Omalizumab in Real World Settings: A Systematic Literature Review of Non-Randomized Studies
Reynold A Panettieri, MD Jonathan Corren, MD Susan Gabriel, MSc Kimberly M. Ruiz, EdM Bethany Sawchyn, PharmD Jennifer A. Colby, PharmD Meryl Mendelson, MD
Reynold A Panettieri, MD Jonathan Corren, MD Susan Gabriel, MSc Kimberly M. Ruiz, EdM Bethany Sawchyn, PharmD Jennifer A. Colby, PharmD Meryl Mendelson, MD
Defining the Percentage of T Helper 17 Cells in Patients with Eczema and Allergic Disease
Ranjeet Minocha, MD John M. Routes, MD FAAAAI Mary Hintermeyer, APNP Trivikram Dasu, PhD Erin Hammelev Tucker Keuter Aniko Szabo, PhD James W. Verbsky, MD PhD
Ranjeet Minocha, MD John M. Routes, MD FAAAAI Mary Hintermeyer, APNP Trivikram Dasu, PhD Erin Hammelev Tucker Keuter Aniko Szabo, PhD James W. Verbsky, MD PhD
Prevalence of Atopic Diseases in Patients with Humoral Primary Immunodeficiency: A Comparison of a Single Center and the US Immunodeficiency Network (USIDNET)
Alice S. Chau, MD Artemio M. Jongco III, MD PhD MPH Laura Helfner, MD James C. Fagin, MD Vincent R. Bonagura, MD FAAAAI
Alice S. Chau, MD Artemio M. Jongco III, MD PhD MPH Laura Helfner, MD James C. Fagin, MD Vincent R. Bonagura, MD FAAAAI
Evaluation of Antibody, Cytokine and Mirnas in Patients with Ige-Mediated and Non-IgE Mediated Rhinitis in Brazilian Subjects Triggered By House Dust Allergen Exposure
Ernesto A Taketomi Juliana S Miranda Jair Cunha-Júnior, PhD Ana CAM Pajuaba
Ernesto A Taketomi Juliana S Miranda Jair Cunha-Júnior, PhD Ana CAM Pajuaba
Inhibition of Inflammation and Mucus Production By Bordetella Pertussis Whole-Cell Vaccine in a Murine Model of Allergic Rhinitis
Marcelo Vivolo Aun, MD Fernanda Arantes-Costa Francine Maria Almeida Thayse Regina Brüggermann Beatriz Mangueira Saraiva-Romanholo Isabella S Genaro Milton Arruda Martins, MD, PhD Jorge Kalil, MD, PhD Pedro Giavina-Bianchi, MD PhD
Marcelo Vivolo Aun, MD Fernanda Arantes-Costa Francine Maria Almeida Thayse Regina Brüggermann Beatriz Mangueira Saraiva-Romanholo Isabella S Genaro Milton Arruda Martins, MD, PhD Jorge Kalil, MD, PhD Pedro Giavina-Bianchi, MD PhD
Usefulness of Component-Resolved Diagnosis (CRD) in Patients with Pet Allergy
Wolfgang Hemmer, PhD Gabriele Sesztak-Greinecker, MD Felix Wantke, MD FAAAAI Stefan Wohrl, MD, MSc, FAAAAI
Wolfgang Hemmer, PhD Gabriele Sesztak-Greinecker, MD Felix Wantke, MD FAAAAI Stefan Wohrl, MD, MSc, FAAAAI
B Cell Isotype Switching Is Dependent upon the Duration of B Cell Activation and Dose of Antigen
Tae Kwan Lee Se Jin An Ji-Mok Kim Jae Ho Lee, MD PhD
Tae Kwan Lee Se Jin An Ji-Mok Kim Jae Ho Lee, MD PhD
2205
Indoor Allergens and Fungi
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Vacuolar Serine Protease Major Allergen of Fusarium Proliferatum
Horng-Der Shen Hsiao-Yun Tai Chang-Ching Yeh Keh-Gong Wu
Horng-Der Shen Hsiao-Yun Tai Chang-Ching Yeh Keh-Gong Wu
Relationship of Der f1 and Der p1 Levels in House Dust in the Midwestern US
Charles S. Barnes, PhD FAAAAI Freddy Pacheco, MS Jay M. Portnoy, MD FAAAAI
Charles S. Barnes, PhD FAAAAI Freddy Pacheco, MS Jay M. Portnoy, MD FAAAAI
An Exploratory Proof of Concept Study to Quantify the Major Cat Allergens, Fel d1 and Fel d4 from Domestic House Cats
William H. Yang, MD Suzanne Kelly, PhD Nate Stepner, D.Litt Douglas Boeckh, DVM Jacob Karsh, MD Jimmy Yang, MBA
William H. Yang, MD Suzanne Kelly, PhD Nate Stepner, D.Litt Douglas Boeckh, DVM Jacob Karsh, MD Jimmy Yang, MBA
Modulatory Effects of Aspergillus Colonization and Abpa on Blood and Sputum Granulocytes in CF
Yael Gernez Jeffrey Waters Colleen E. Dunn Zoe Davies Cassie Everson Rabindra Tirouvanziam Leonore Herzenberg Richard B. Moss, MD
Yael Gernez Jeffrey Waters Colleen E. Dunn Zoe Davies Cassie Everson Rabindra Tirouvanziam Leonore Herzenberg Richard B. Moss, MD
Mobility of Aeroallergens in Home: Effect of Location of Air Sampling and Implication for Evaluation of Patient Exposure.
Julian Gordon, PhD Paul Detjen, MD Andrea Wachter Prasanthi Gandhi, MBA MPH
Julian Gordon, PhD Paul Detjen, MD Andrea Wachter Prasanthi Gandhi, MBA MPH
Homes Assessed As a Result of Physician Referral Have Higher Fungal Burden
Jill R. Hanson, MD Charles S. Barnes, PhD FAAAAI Jay M. Portnoy, MD FAAAAI
Jill R. Hanson, MD Charles S. Barnes, PhD FAAAAI Jay M. Portnoy, MD FAAAAI
Prevalence of Sensitization to Mold Allergens in Patients with Respiratory Allergy
Barbara Elizondo-Villarreal Sandra N. Gonzalez-Diaz, MD PhD FAAAAI Alfredo Arias-Cruz, MD FAAAAI Lucia Leal-Villarreal Maria Del Carmen Zarate-Hernandez, MD Dulce M Rivero-Arias Olga P Monge Ortega Jr. Jesus A Ibarra-Chavez
Barbara Elizondo-Villarreal Sandra N. Gonzalez-Diaz, MD PhD FAAAAI Alfredo Arias-Cruz, MD FAAAAI Lucia Leal-Villarreal Maria Del Carmen Zarate-Hernandez, MD Dulce M Rivero-Arias Olga P Monge Ortega Jr. Jesus A Ibarra-Chavez
Association of Aspergillus Monosensitization with Asthma and Rhinosinusitis
Julie T. Abraham, MD Maria A. Barcena Blanch, MD Roxana I. Siles, MD
Julie T. Abraham, MD Maria A. Barcena Blanch, MD Roxana I. Siles, MD
Is There a Temporal Relationship Between Outdoor Alternaria alternata Spore Counts and Specific IgE Alternaria alternata Levels?
Hani Hadi, MD Jay M. Portnoy, MD FAAAAI Charles S. Barnes, PhD FAAAAI Vincent Staggs, PhD
Hani Hadi, MD Jay M. Portnoy, MD FAAAAI Charles S. Barnes, PhD FAAAAI Vincent Staggs, PhD
Aerobiology of Yeasts: Viable Colonies and Molecular Identification from Burkard Samples
Josh D. McLoud, M.S. Estelle Levetin, PhD FAAAAI
Josh D. McLoud, M.S. Estelle Levetin, PhD FAAAAI
2206
Exposures, Asthma and Allergic Diseases
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Role of Cadmium and Folate Levels in Risks of Allergic and Respiratory Diseases of Early Childhood: The Mothers and Children's Environmental Health Study
Ja Hyeong Kim, MD Eun-Hee Ha, MD Hye sook Park, MD Mina Ha, MD Yun-Chul Hong, MD Jin-A Jung, MD Yangho Kim, MD
Ja Hyeong Kim, MD Eun-Hee Ha, MD Hye sook Park, MD Mina Ha, MD Yun-Chul Hong, MD Jin-A Jung, MD Yangho Kim, MD
Prevalence of Respiratory Viruses in Patients with Acute Respiratory Infections in Korea
Jin-sung Park Hee-Dong Jung Hyang-Min Jung Sung-Soon Kim Chang-Keun Kim, MD FAAAAI
Jin-sung Park Hee-Dong Jung Hyang-Min Jung Sung-Soon Kim Chang-Keun Kim, MD FAAAAI
A Two Pronged Approach to the Detection of Cimex Lectularius (common bed bug) Using Novel Bed Bug Proteins
Natasha Gordon, PhD Luke O'Shaughnessy, PhD David Fitzpatrick, PhD Sean Doyle, PhD Bruce Mitchell, MD
Natasha Gordon, PhD Luke O'Shaughnessy, PhD David Fitzpatrick, PhD Sean Doyle, PhD Bruce Mitchell, MD
Delay in Asthma Diagnosis and Risk of Common Respiratory Infection in Young Children
Mir Ali Elizabeth Krusemark Chung I. Wi, MD Sunghwan Sohn, PhD Hongfang Liu, PhD Euijung Ryu, PhD Young J. Juhn, MD MPH
Mir Ali Elizabeth Krusemark Chung I. Wi, MD Sunghwan Sohn, PhD Hongfang Liu, PhD Euijung Ryu, PhD Young J. Juhn, MD MPH
Prevalence of Sensitization to Airborne Allergens Among Elderly Population
Adile Berna Dursun Filiz Mercantepe Vehbi Ayhan
Adile Berna Dursun Filiz Mercantepe Vehbi Ayhan
Eosinophilic Bronchitis Caused By Exposure to Wheat Flour in the Workplace
Olga Vega Matute, MD Marta M. Ferrer, MD PhD FAAAAI Carmen M. Damelio, MD Amalia Bernad, MD Roselle Catherine Yu Madamba Gabriel Gastaminza, MD PhD
Olga Vega Matute, MD Marta M. Ferrer, MD PhD FAAAAI Carmen M. Damelio, MD Amalia Bernad, MD Roselle Catherine Yu Madamba Gabriel Gastaminza, MD PhD
Supplementation with the Antioxidant Sulforaphane Does Not Protect Airway Epithelium Against O3-Induced Injury In Vivo
Michelle L. Hernandez, MD Katherine Mills, BA Allison J. Burbank Matthew J Kesic, PhD Charity Duran, PhD David B. Peden, MD MS FAAAAI
Michelle L. Hernandez, MD Katherine Mills, BA Allison J. Burbank Matthew J Kesic, PhD Charity Duran, PhD David B. Peden, MD MS FAAAAI
The Relevance of Residential Environment to Atopy Prevalence Based on Skin Prick Test in Rural Community Cohort in Korea.
Eun-Jin Kim, PhD Dankyu Yoon Hye-Sun Lim Jeom-Kyu Lee Joo Shil Lee, PhD
Eun-Jin Kim, PhD Dankyu Yoon Hye-Sun Lim Jeom-Kyu Lee Joo Shil Lee, PhD
Ultraviolet Index Is Associated with the Prevalence of Eczema in Boys
Koichi Yoshida, MD Mari Sasaki, MD Yuichi Adachi, MD, PhD Emi Kawaguchi, MD Masayuki Akashi, MD Yukihiro Ohya, MD, PhD Hiroshi Odajima, MD, PhD Akira Akasawa, MD, PhD
Koichi Yoshida, MD Mari Sasaki, MD Yuichi Adachi, MD, PhD Emi Kawaguchi, MD Masayuki Akashi, MD Yukihiro Ohya, MD, PhD Hiroshi Odajima, MD, PhD Akira Akasawa, MD, PhD
Occupational Contact Urticaria to Cow's Milk in the Absence of Cow's Milk Allergy in a Cheesemaker
Claire Mailhol Anne Marie Rabain Julie Herry Fabienne Cantrelle-Mathat Alain Didier, MD PhD
Claire Mailhol Anne Marie Rabain Julie Herry Fabienne Cantrelle-Mathat Alain Didier, MD PhD
Observational Study in Patients with Hymenoptera Allergy: Role of Occupational Exposure, Allergen Immunotherapy, and Indications for Prevention
Alessandra Toletone Susanna Voltolini, MD Donatella Bignardi Paola Minale Costantino Troise, MD Giovanni Passalacqua, MD Guglielmo Dini Emanuela Massa Alessio Signori Paolo Durando
Alessandra Toletone Susanna Voltolini, MD Donatella Bignardi Paola Minale Costantino Troise, MD Giovanni Passalacqua, MD Guglielmo Dini Emanuela Massa Alessio Signori Paolo Durando
2207
Drug Allergy Diagnosis and Management
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Value of Basophil Activation Test for Evaluating Immediate Reactions to Proton Pump Inhibitors
Maria Salas, MD, PhD Esther Barrionuevo, MD, PhD Inmaculada Doña, MD, PhD Oliver Muñoz-Daga Francisca Gómez, MD, PhD Tahia D. Fernandez, PhD Adriana Ariza, PhD Maria Isabel Montañez, PhD Cristobalina Mayorga, PhD Miguel Blanca, MD, PhD María José Torres, MD, PhD
Maria Salas, MD, PhD Esther Barrionuevo, MD, PhD Inmaculada Doña, MD, PhD Oliver Muñoz-Daga Francisca Gómez, MD, PhD Tahia D. Fernandez, PhD Adriana Ariza, PhD Maria Isabel Montañez, PhD Cristobalina Mayorga, PhD Miguel Blanca, MD, PhD María José Torres, MD, PhD
Evaluated the Diagnostic Utility of Interferon-Gamma Enzyme-Linked Immunospot (ELISPOT) Assays in 117 Patients with Non-Immediate Drug Hypersensitivity Reactions
Suda Punrin Pattarawat Thantiworasit, MSc Pungjai Mongkolpathumrat Jettanong Klaewsongkram, MD
Suda Punrin Pattarawat Thantiworasit, MSc Pungjai Mongkolpathumrat Jettanong Klaewsongkram, MD
Diagnostic Tests in Hypersensitivity to Oxaliplatin Beyond Clinical History
Paula Lopez-Gonzalez, MD Ricardo Madrigal-Burgaleta, MD Pilar Berges-Gimeno, PhD Emilio Solano-Solares, MD Laura Carpio-Escalona, MD Emilio Alvarez-Cuesta, MD PhD
Paula Lopez-Gonzalez, MD Ricardo Madrigal-Burgaleta, MD Pilar Berges-Gimeno, PhD Emilio Solano-Solares, MD Laura Carpio-Escalona, MD Emilio Alvarez-Cuesta, MD PhD
Determining Non-Irritating Concentration for Intradermal Skin Test with Commonly Prescribed Antibiotics in Korean Adults
Ha Kyeong Won Min-Suk Yang, MD, PhD Woo-Jung Song, MD Yoon-Seok Chang, MD PhD Sang Heon Cho, MD, PhD Heung-Woo Park, MD, PhD Kyung-Up Min, MD,PhD
Ha Kyeong Won Min-Suk Yang, MD, PhD Woo-Jung Song, MD Yoon-Seok Chang, MD PhD Sang Heon Cho, MD, PhD Heung-Woo Park, MD, PhD Kyung-Up Min, MD,PhD
The Effect of Penicillin Allergy Testing on Future Healthcare Utilization and Morbidity: A Case-Control Study
Eric M. Macy, MD FAAAAI Yu-Hsiang Shu, MS PhD
Eric M. Macy, MD FAAAAI Yu-Hsiang Shu, MS PhD
The Effect of a Penicillin Allergy Algorithm on Perioperative Antibiotic Choice
Joseph A. Grillo, MD Karen Ravin, MD Magee L DeFelice, MD
Joseph A. Grillo, MD Karen Ravin, MD Magee L DeFelice, MD
Safety of Two-Step Graded Challenges to Beta-Lactams Using a Single-Blinded Placebo-Controlled Protocol
Melissa Iammatteo, MD Denisa Ferastraoaru, MD MSc Santiago Alvarez Arango, MD Niharika Thota, MD Ayobami Akenroye, MD, MPH Elina Jerschow, M.D., M.Sc.
Melissa Iammatteo, MD Denisa Ferastraoaru, MD MSc Santiago Alvarez Arango, MD Niharika Thota, MD Ayobami Akenroye, MD, MPH Elina Jerschow, M.D., M.Sc.
Amoxicillin Challenges in Marine Recruits Reporting Penicillin Allergy
Jeremy D. Waldram, MD Mark H. Tucker, MD
Jeremy D. Waldram, MD Mark H. Tucker, MD
Outcomes and Safety of Single-Step and Multi-Step Antibiotic Drug Challenges
Stephanie L. Mawhirt, DO Luz S. Fonacier, MD FAAAAI Rose Calixte, PhD Mark A. Davis-Lorton, MD FAAAAI Marcella R. Aquino, MD FAAAAI
Stephanie L. Mawhirt, DO Luz S. Fonacier, MD FAAAAI Rose Calixte, PhD Mark A. Davis-Lorton, MD FAAAAI Marcella R. Aquino, MD FAAAAI
Graded Escalating Doses of Trimethoprim-Sulfamethoxazole in Immunocompetent Patients with Previous History of Delayed Rash to Sulfa Antimicrobials
Vuong A. Nayima, DO John T. Anderson, MD
Vuong A. Nayima, DO John T. Anderson, MD
Evaluating Risk Factors for a Positive Oral Challenge Despite Negative Penicillin Skin Testing
Megan S. Motosue, MD Sara M. May, MD Jay Jin, MD PhD Miguel A. Park, MD
Megan S. Motosue, MD Sara M. May, MD Jay Jin, MD PhD Miguel A. Park, MD
Reaction Doses in Aspirin Desensitization for Aspirin-Exacerbated Respiratory Disease
Charles Schuler, MD James L. Baldwin, MD FAAAAI Alan P. Baptist, MD MPH FAAAAI
Charles Schuler, MD James L. Baldwin, MD FAAAAI Alan P. Baptist, MD MPH FAAAAI
AERD: A Composite Symptom Score to Identify Positive Aspirin/NSAID Challenges
Kevin A. Cook, MD Nathan Wineinger, PhD Kristen M Dazy, MD Katharine M. Woessner, MD FAAAAI Ronald A. Simon, MD FAAAAI Andrew White, MD, FAAAAI
Kevin A. Cook, MD Nathan Wineinger, PhD Kristen M Dazy, MD Katharine M. Woessner, MD FAAAAI Ronald A. Simon, MD FAAAAI Andrew White, MD, FAAAAI
The Investigation of Suspected Beta-Lactam Allergy in Children; Comparison of Contemporary Clinical Practice By International Specialists
Ru-Xin M. Foong Kirsty Logan Michael Perkin George Du Toit, MD FAAAAI
Ru-Xin M. Foong Kirsty Logan Michael Perkin George Du Toit, MD FAAAAI
Hypersensitivity Reactions to Rituximab: 53 Successful Desensitizations in 7 Patients with Severe, Near-Fatal Reactions
Yuval Tal, MD PhD Dina Ben Yehuda, MD Meir Shalit, MD FAAAAI Eyal Lebel, MD
Yuval Tal, MD PhD Dina Ben Yehuda, MD Meir Shalit, MD FAAAAI Eyal Lebel, MD
Experience with Desensitizations to Taxanes in an Allergy Department in Madrid (Spain)
Mercedes Sáenz de Santa María, MD Gabriela Zambrano, M.D. María L. Baeza, MD, PhD Sonsoles Infante, MD Alberto Alvarez-Perea, MD Pilar Tornero, MD
Mercedes Sáenz de Santa María, MD Gabriela Zambrano, M.D. María L. Baeza, MD, PhD Sonsoles Infante, MD Alberto Alvarez-Perea, MD Pilar Tornero, MD
Anaphylactic Shock Caused By Moxifloxacin without Cross-Reactivity to Other Fluoroquinolones
Rung-chi Li, DO, PhD Jonathan A. Bernstein, MD FAAAAI
Rung-chi Li, DO, PhD Jonathan A. Bernstein, MD FAAAAI
Descriptive Analysis of Patients with Allergic Reactions to Fluoroquinolones
Esther Barrionuevo, MD, PhD Inmaculada Doña, MD, PhD Francisca Gómez, MD, PhD Oliver Muñoz-Daga Arturo Ruiz, MD Antonio Guzman Maria Auxiliadora Guerrero Maria Dolores Ruiz Rosa Garcia Miguel Blanca, MD, PhD María José Torres, MD, PhD
Esther Barrionuevo, MD, PhD Inmaculada Doña, MD, PhD Francisca Gómez, MD, PhD Oliver Muñoz-Daga Arturo Ruiz, MD Antonio Guzman Maria Auxiliadora Guerrero Maria Dolores Ruiz Rosa Garcia Miguel Blanca, MD, PhD María José Torres, MD, PhD
Effectiveness of Premedication and Rapid Desensitization in Hypersensitivity to L-Asparaginase
Jin-Tack Kim, MD. PhD Hwan Soo Kim, MD Yoon Hong Chun, MD Jong-seo Yoon, MD, PhD Hyun Hee Kim, MD
Jin-Tack Kim, MD. PhD Hwan Soo Kim, MD Yoon Hong Chun, MD Jong-seo Yoon, MD, PhD Hyun Hee Kim, MD
An Adolescent Male Presenting with Nonpigmenting Fixed Drug Eruption to Ceftriaxone
Adam Byrne, M.Sc, MD Moshe Ben-Shoshan, MD, MSc
Adam Byrne, M.Sc, MD Moshe Ben-Shoshan, MD, MSc
Diagnosis and Management of Infusion-Related Hypersensitivity Reactions to Enzyme Replacement Therapy for Lysosomal Diseases: The Role of Desensitization
Carolina Sanchez Aranda Luis Felipe C. Ensina, MD Inês Camelo Nunes Marcia Mallozi, MD Ana Maria Martins Dirceu Sole, MD PhD FAAAAI
Carolina Sanchez Aranda Luis Felipe C. Ensina, MD Inês Camelo Nunes Marcia Mallozi, MD Ana Maria Martins Dirceu Sole, MD PhD FAAAAI
The Role of Carbapenems and Cephalosporines in Patients with Confirmed Penicillin Allergy
Mona Sulaiman Al-Ahmad, MD Tito Rodriguez Bouza
Mona Sulaiman Al-Ahmad, MD Tito Rodriguez Bouza
A Case Report of Dress with Prolonged Latency Period Related to Zonisamide in a Child
Fatima Khan Joel Mendelson, MD
Fatima Khan Joel Mendelson, MD
Retrospective Review of Beta Lactam Allergy Prevalence in a Referral Population
Andrew Wakeman, BSc(Hon) Alexander Singer, MB BaO BCh, CCFP Elissa Michele Abrams, MD, FRCPC Thomas V. Gerstner, MD, FRCPC
Andrew Wakeman, BSc(Hon) Alexander Singer, MB BaO BCh, CCFP Elissa Michele Abrams, MD, FRCPC Thomas V. Gerstner, MD, FRCPC
Perioperative Use of Cefazolin in Patients with Reported Penicillin Allergy
Allison Ramsey, MD Mary Staicu, PharmD Leanna Liu
Allison Ramsey, MD Mary Staicu, PharmD Leanna Liu
Patients Taking Amoxicillin-Clavulanic Can Become Simultaneously Sensitized to Both Drugs
Adriana Ariza, PhD Tahia D. Fernandez, PhD Cristobalina Mayorga, PhD Maria Salas, MD, PhD Nekane Barbero, PhD Maria Isabel Montañez, PhD Ángela Martín-Serrano Ruben Fernandez Luisa Galindo, RN Miguel Blanca, MD, PhD María José Torres, MD, PhD
Adriana Ariza, PhD Tahia D. Fernandez, PhD Cristobalina Mayorga, PhD Maria Salas, MD, PhD Nekane Barbero, PhD Maria Isabel Montañez, PhD Ángela Martín-Serrano Ruben Fernandez Luisa Galindo, RN Miguel Blanca, MD, PhD María José Torres, MD, PhD
Morbidity in Pregnant Women with Group-B Streptococcus Infection and Unverified Penicillin Allergy
Shilpa Desai, MD Qiaoling Chen, MS Michael S. Kaplan, MD FAAAAI Scott Rasgon, MD Eric M. Macy, MD FAAAAI
Shilpa Desai, MD Qiaoling Chen, MS Michael S. Kaplan, MD FAAAAI Scott Rasgon, MD Eric M. Macy, MD FAAAAI
Hypersensitivity to Butylscopolamine: A Case Report.
Francisco Javier Iglesias-Souto, Allergy Department Olga Arbazagoitia, Allergy Department Jacob Rosquete, Internal Medicine Department
Francisco Javier Iglesias-Souto, Allergy Department Olga Arbazagoitia, Allergy Department Jacob Rosquete, Internal Medicine Department
Immune-Mediated Reactions to Vancomycin: A Systematic Review
Jasmit S. Minhas, MD Paige G. Wickner, MD MPH FAAAAI Aidan A. Long, MD FAAAAI Aleena Banerji, MD Kimberly G Blumenthal, M.D.
Jasmit S. Minhas, MD Paige G. Wickner, MD MPH FAAAAI Aidan A. Long, MD FAAAAI Aleena Banerji, MD Kimberly G Blumenthal, M.D.
Peer Survey of Alert Fatigue in Physicians in a Large Inner City Training Hospital: Does It Affect Drug Allergy Surveillance?
Adam El Sehamy, MD Naureen Kabani, MD Amanda Nussdorf, BS. YiFeng Chen, M.D. Rauno Joks, MD
Adam El Sehamy, MD Naureen Kabani, MD Amanda Nussdorf, BS. YiFeng Chen, M.D. Rauno Joks, MD
Fixed Drug Eruption to Arylpropionic Acids
Abdonias Rodriguez Gamboa, MD Dasha Roa Medellin, MD Margarita Acevedo Matos, MD Blanca Noguerado, MD Patricia Rojas, MD Manuel De Barrio, MD
Abdonias Rodriguez Gamboa, MD Dasha Roa Medellin, MD Margarita Acevedo Matos, MD Blanca Noguerado, MD Patricia Rojas, MD Manuel De Barrio, MD
Etiologies and Clinical Characteristics of 97 Patients Diagnosed with Severe Cutaneous Adverse Reactions from Six Tertiary Medical Centers in Thailand
Jettanong Klaewsongkram, MD Pawinee Rerknimitr, MD Ticha Rerkpattanapipat, MD Kumutnart Chanprapaph, MD Papapit Tuchinda, MD Leena Chularojanamontri, MD Napatra Tovanabutra, MD Wareeporn Disphanurat, MD Panlop Chakkavittumrong, MD Chutika Srisuttiyakorn, MD Pattarawat Thantiworasit, MSc Chonlaphat Sukasem, B. Pharm, PhD Yuttana Srinoulprasert, MD, PhD
Jettanong Klaewsongkram, MD Pawinee Rerknimitr, MD Ticha Rerkpattanapipat, MD Kumutnart Chanprapaph, MD Papapit Tuchinda, MD Leena Chularojanamontri, MD Napatra Tovanabutra, MD Wareeporn Disphanurat, MD Panlop Chakkavittumrong, MD Chutika Srisuttiyakorn, MD Pattarawat Thantiworasit, MSc Chonlaphat Sukasem, B. Pharm, PhD Yuttana Srinoulprasert, MD, PhD
Epidemiology and Incidence of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record
Aleena Banerji, MD Kimberly G Blumenthal, M.D. Kenneth H Lai, MA Li Zhou, MD, PhD
Aleena Banerji, MD Kimberly G Blumenthal, M.D. Kenneth H Lai, MA Li Zhou, MD, PhD
The Low Expression of Tim-3 in Patients with Maculopapular Exanthema (EMP) Induced By Drugs Can Impaired Disease Control.
Tahia D. Fernandez, PhD Francisca Palomares, PhD Maria Salas, MD, PhD Inmaculada Doña, MD, PhD Esther Barrionuevo, MD, PhD Adriana Ariza, PhD Raquel Jurado Miguel Blanca, MD, PhD Cristobalina Mayorga, PhD María José Torres, MD, PhD
Tahia D. Fernandez, PhD Francisca Palomares, PhD Maria Salas, MD, PhD Inmaculada Doña, MD, PhD Esther Barrionuevo, MD, PhD Adriana Ariza, PhD Raquel Jurado Miguel Blanca, MD, PhD Cristobalina Mayorga, PhD María José Torres, MD, PhD
Allergy to Benznidazole: Cross-Reactivity with Other Nitroimidazoles
Blanca Noguerado, MD Patricia Rojas, MD Maria Calderon, MD Cristina Morales, MD Pilar Tornero, MD
Blanca Noguerado, MD Patricia Rojas, MD Maria Calderon, MD Cristina Morales, MD Pilar Tornero, MD
Allergy to Heparins.
Francisco Javier Ruano Pérez, MD Diana Perez Alzate, MD Natalia Blanca-López, MD PhD Maria Luisa Somoza, MD Maria Vazquez De La Torre, MD Maria Isabel Garcimartin, MD Elisa Haroun, MD Gabriela Canto, MD, PhD
Francisco Javier Ruano Pérez, MD Diana Perez Alzate, MD Natalia Blanca-López, MD PhD Maria Luisa Somoza, MD Maria Vazquez De La Torre, MD Maria Isabel Garcimartin, MD Elisa Haroun, MD Gabriela Canto, MD, PhD
Allergy Patterns in a Tertiary Care Referral Center
Maria A. Barcena Blanch, MD Julie T. Abraham, MD David M. Lang, MD FAAAAI
Maria A. Barcena Blanch, MD Julie T. Abraham, MD David M. Lang, MD FAAAAI
Allergic Reactions to Dipyrone: Immediate and Non-Immediate Responses
Inmaculada Doña, MD, PhD Francisca Gómez, MD, PhD Tahia D. Fernandez, PhD Adriana Ariza, PhD Arturo Ruiz, MD Maria Isabel Sánchez Rivas Cristina De Leyva Maria Isabel Montañez Antonio Guzman Miguel Blanca, MD, PhD Maria J Torres, MD, PhD
Inmaculada Doña, MD, PhD Francisca Gómez, MD, PhD Tahia D. Fernandez, PhD Adriana Ariza, PhD Arturo Ruiz, MD Maria Isabel Sánchez Rivas Cristina De Leyva Maria Isabel Montañez Antonio Guzman Miguel Blanca, MD, PhD Maria J Torres, MD, PhD
Adverse Drug Reactions of Ranitidine: A Pharmacovigilance Study in Korea
Kyung Hee Park Da Woon Sim Hye Jung Park Kyoung-Yong Jeong Jae-Hyun Lee Jung-Won Park
Kyung Hee Park Da Woon Sim Hye Jung Park Kyoung-Yong Jeong Jae-Hyun Lee Jung-Won Park
Broken Heart Syndrome (Takotsubo Cardiomyopathy) Induced By Epinephrine
Muhammad A. Imran, MD Haroon Khalid, MBBS Saima Karim, DO Selina A. Gierer, DO
Muhammad A. Imran, MD Haroon Khalid, MBBS Saima Karim, DO Selina A. Gierer, DO
2208
Anaphylaxis and Venom Immunotherapy
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Systemic Reactions to Aeroallergen Immunotherapy: A Retrospective Review of Our Practice
Matthew T. Tallar, MD Leslie M. Gimenez, MD FAAAAI Heidi T. V. Zafra, MD FAAAAI Asriani M. Chiu, MD FAAAAI
Matthew T. Tallar, MD Leslie M. Gimenez, MD FAAAAI Heidi T. V. Zafra, MD FAAAAI Asriani M. Chiu, MD FAAAAI
Safety and Efficacy of Hymenoptera and Fire Ant Rush Immunotherapy in Children
Wiparat Manuyakorn, MD, PhD Suwat Benjaponpitak, MD Wasu Kamchaisatian, MD Cherapat Sasisakulporn, B.Sc. Wanlapa Teawsomboonkit, RN
Wiparat Manuyakorn, MD, PhD Suwat Benjaponpitak, MD Wasu Kamchaisatian, MD Cherapat Sasisakulporn, B.Sc. Wanlapa Teawsomboonkit, RN
Analysis of Venom Hypersensitivity Reactions and Subsequent Preventative Management in VA Patient Population
Priya J. Patel, MD Alan H. Wolff, MD
Priya J. Patel, MD Alan H. Wolff, MD
Platelet Activating Factor Acetylhydrolase Levels at Baseline and during Allergic Reactions
Jacob D. Kattan, MD Thomas Kraus, PhD Thomas Moran, PhD Hugh A. Sampson, MD FAAAAI
Jacob D. Kattan, MD Thomas Kraus, PhD Thomas Moran, PhD Hugh A. Sampson, MD FAAAAI
Baseline CD63 Expression in Patients with Exercise Induced Anaphylaxis (EIA)
Liat Nachshon, MD Moshe Appel, PhD Michael R Goldberg, MD PhD Arnon Elizur, MD Yitzhak Katz, MD FAAAAI
Liat Nachshon, MD Moshe Appel, PhD Michael R Goldberg, MD PhD Arnon Elizur, MD Yitzhak Katz, MD FAAAAI
Exercise-Induced Anaphylaxis Successfully Treated with Hydroxychloroquine
Aaron K. Kobernick, MD, MPH Maya R. Jerath, MD PhD
Aaron K. Kobernick, MD, MPH Maya R. Jerath, MD PhD
Wheat-Dependent, Exercise-Induced Anaphylaxis Can be Elicited without Exercise (And With Other Co-factors)
Morten J. Christensen, MD Esben Eller, MSc, PhD Charlotte G Mortz, MD, PhD Knut Brockow, MD Carsten Bindslev-Jensen, MD PhD DMSci FAAAAI
Morten J. Christensen, MD Esben Eller, MSc, PhD Charlotte G Mortz, MD, PhD Knut Brockow, MD Carsten Bindslev-Jensen, MD PhD DMSci FAAAAI
Pretreatment with Ibrutinib, a Bruton's Tyrosine Kinase Inhibitor, Reduces Passive Systemic Anaphylaxis in a Murine Model
Jennifer A. Regan, MD, PhD Rebecca Krier-Burris, MS Jeremy O'Sullivan, PhD Paul Bryce, PhD Bruce S. Bochner, MD FAAAAI
Jennifer A. Regan, MD, PhD Rebecca Krier-Burris, MS Jeremy O'Sullivan, PhD Paul Bryce, PhD Bruce S. Bochner, MD FAAAAI
Optimal Needle Length of Epinephrine Prefilled Syringe in Thai Infants
Buntita Bamrungchaowkasem, MD Wiparat Manuyakorn, MD, PhD Nichanun Ruangwattanapaisarn, MD Suwat Benjaponpitak, MD Wasu Kamchaisatian, MD
Buntita Bamrungchaowkasem, MD Wiparat Manuyakorn, MD, PhD Nichanun Ruangwattanapaisarn, MD Suwat Benjaponpitak, MD Wasu Kamchaisatian, MD
Effects of Intramuscular Epinephrine on Cardiovascular Parameters during IgE-Mediated Allergic Reactions to Peanut
Monica Ruiz-Garcia, MD Carl Hayward, MD PhD Alistair Tang, BSc Andrew Clark, MRCPCH MD Isabel J. Skypala, PhD RD Stephen R. Durham, MA MD FRCP Alexander R Lyon, PhD FRCP Robert J. Boyle, MBChB PhD Paul J. Turner, FRACP PhD
Monica Ruiz-Garcia, MD Carl Hayward, MD PhD Alistair Tang, BSc Andrew Clark, MRCPCH MD Isabel J. Skypala, PhD RD Stephen R. Durham, MA MD FRCP Alexander R Lyon, PhD FRCP Robert J. Boyle, MBChB PhD Paul J. Turner, FRACP PhD
Correct Use of Epinephrine Autoinjectors in Relation to Health Literacy in Patients with Food Allergies
Maureen Egan, MD Julie Wang, MD FAAAAI
Maureen Egan, MD Julie Wang, MD FAAAAI
When Is Epinephrine Used in Anaphylaxis?
Alberto Alvarez-Perea, MD Margarita Tomás-Pérez, MD Beatriz Ameiro, MD Patricia Martinez-Lezcano, MD Gabriela Zambrano, MD María L. Baeza, MD, PhD
Alberto Alvarez-Perea, MD Margarita Tomás-Pérez, MD Beatriz Ameiro, MD Patricia Martinez-Lezcano, MD Gabriela Zambrano, MD María L. Baeza, MD, PhD
Prescription of Epinephrine Autoinjectors to Children with Food Allergies in a General Pediatric Clinic
Tamar Weinberger Ari Zelig, MD Allison Gault, MD Julie Wang, MD FAAAAI
Tamar Weinberger Ari Zelig, MD Allison Gault, MD Julie Wang, MD FAAAAI
Epinephrine Use in the New York City Public School District
Elizabeth Feuille, MD Cheryl Lawrence Caroline Volel Scott H. Sicherer, MD FAAAAI Julie Wang, MD FAAAAI
Elizabeth Feuille, MD Cheryl Lawrence Caroline Volel Scott H. Sicherer, MD FAAAAI Julie Wang, MD FAAAAI
Epinephrine Use in Schools for Food-Induced Anaphylaxis
Angela Tsuang, MD, MSc Haidi Demain Kathleen Patrick, RN Michael Pistiner, MD MMSc Julie Wang, MD FAAAAI
Angela Tsuang, MD, MSc Haidi Demain Kathleen Patrick, RN Michael Pistiner, MD MMSc Julie Wang, MD FAAAAI
EPIPEN4SCHOOLS® Survey Combined Analysis: Prevalence and Triggers of Anaphylactic Events
Martha V. White, MD, CPI Suyapa Silvia, PhD Kelly Hollis, MBA Margaret J. Wooddell, PhD, MBA Diana Goss, BS Dawn Odom, MS Jennifer Bartsch, MStat Susan L. Hogue, PharmD, MPH
Martha V. White, MD, CPI Suyapa Silvia, PhD Kelly Hollis, MBA Margaret J. Wooddell, PhD, MBA Diana Goss, BS Dawn Odom, MS Jennifer Bartsch, MStat Susan L. Hogue, PharmD, MPH
EPIPEN4SCHOOLS® Survey Combined Analysis: Staff Training and Use of Epinephrine Auto-Injectors
Susan L. Hogue, PharmD, MPH Suyapa Silvia, PhD Kelly Hollis, MBA Margaret J. Wooddell, PhD, MBA Diana Goss, BS Dawn Odom, MS Darryl Cooney, MS Martha V. White, MD, CPI
Susan L. Hogue, PharmD, MPH Suyapa Silvia, PhD Kelly Hollis, MBA Margaret J. Wooddell, PhD, MBA Diana Goss, BS Dawn Odom, MS Darryl Cooney, MS Martha V. White, MD, CPI
Likelihood of Having Self-Injectable Epinephrine in Adult and Pediatric Patients Presenting for Evaluation of Food Allergy
Carolyn H. Baloh, MD Daniel Winger, MS Tara Shankar, MD Merritt L. Fajt, MD Todd David Green, MD FAAAAI
Carolyn H. Baloh, MD Daniel Winger, MS Tara Shankar, MD Merritt L. Fajt, MD Todd David Green, MD FAAAAI
Recurrent Idiopathic Anaphylaxis in a Woman after Suspected Food Poisoning
Carl B. Lauter, MD, FAAAAI
Carl B. Lauter, MD, FAAAAI
An Interdisciplinary Approach to Perioperative Anaphylaxis: A Tertiary Pediatric Center Experience
Atoosa Kourosh, MD, MPH Karen Thursday S. Tuano, MD Dipika Patel, MD Nicholas Rider, DO Sara Anvari, MD Lenora M. Noroski, MD, MPH Kristin H. Dillard, MD Filiz O. Seeborg, MD, MPH
Atoosa Kourosh, MD, MPH Karen Thursday S. Tuano, MD Dipika Patel, MD Nicholas Rider, DO Sara Anvari, MD Lenora M. Noroski, MD, MPH Kristin H. Dillard, MD Filiz O. Seeborg, MD, MPH
Increasing Trends in the Nationwide Incidence of Anaphylaxis Visiting Emergency Room in Korea from 2007 to 2013
Young Min Ahn, MD Eun-Hee Chung Youn Kyung Won Yoo Mi Chung
Young Min Ahn, MD Eun-Hee Chung Youn Kyung Won Yoo Mi Chung
Analysis of Anaphylaxis Trigger Factors and Treatment during a Five Year Period in a Vilnius University Hospital
Audra Blaziene Neringa Buterleviciute Viktorija Paltarackiene Lawrence M. DuBuske, MD, FAAAAI
Audra Blaziene Neringa Buterleviciute Viktorija Paltarackiene Lawrence M. DuBuske, MD, FAAAAI
Accuracy of ICD-10 Coding for Anaphylaxis
Monthida Uthairat, MD Teeranai Sakulchit, MD Pasuree Sangsupawanich, MD, PhD
Monthida Uthairat, MD Teeranai Sakulchit, MD Pasuree Sangsupawanich, MD, PhD
The Incidence of Anaphylaxis in a Large Health Maintenance Organization: A Review of International Classification of Diseases Coding and Epinephrine Auto-Injector Prescribing
Deena Pourang, MD Javed Sheikh, MD FAAAAI Shefali A. Samant, MD Michael Batech Michael S. Kaplan, MD FAAAAI
Deena Pourang, MD Javed Sheikh, MD FAAAAI Shefali A. Samant, MD Michael Batech Michael S. Kaplan, MD FAAAAI
Alpha-Gal Hypersensitivity: A Case Series from Good Ol' Rocky Top Tennessee
Mike Tankersley, MD FAAAAI Alan DeJarnatt, MD Ross DeJarnatt
Mike Tankersley, MD FAAAAI Alan DeJarnatt, MD Ross DeJarnatt
A Case of Idiopathic Systemic Capillary Leak Syndrome: Masquerader of Anaphylaxis – an Emblematic Case from a Cohort of 21 Patients
Maddalena A. Wu Marta Mansi, MD Andrea Zanichelli Avner Reshef, MD Marco Cicardi
Maddalena A. Wu Marta Mansi, MD Andrea Zanichelli Avner Reshef, MD Marco Cicardi
Comparison of Pediatric Anaphylaxis at Montreal Children's Hospital and British Columbia Children's Hospital: Rate, Clinical Characteristics, Triggers and Management
Alison YM Lee, MD Paul Enarson, MD, PhD Ann Clarke, MD, MSc Sebastian La Vieille, MD Harley Eisman, MD Edmond S. Chan, MD FAAAAI Christopher Mill, BSc, MPH Lawrence Joseph, PhD Moshe Ben-Shoshan
Alison YM Lee, MD Paul Enarson, MD, PhD Ann Clarke, MD, MSc Sebastian La Vieille, MD Harley Eisman, MD Edmond S. Chan, MD FAAAAI Christopher Mill, BSc, MPH Lawrence Joseph, PhD Moshe Ben-Shoshan
A Law Is Not Enough: Geographical Disparities in Stock Epinephrine Access in Kansas
Marissa A. Love, MD Madison Breeden, BS Kyle Dack, BA Alyssa Milner, BA Andrew C. Rorie, MD Selina A. Gierer, DO
Marissa A. Love, MD Madison Breeden, BS Kyle Dack, BA Alyssa Milner, BA Andrew C. Rorie, MD Selina A. Gierer, DO
Anaphylaxis Cases Treated By out-of-Hospital EMS in Western Quebec
Magdalena J. Grzyb, MD Ann Clarke, MD, MSc Nofar Kimchi Colette Lachaine Sebastian La Vieille, MD Lawrence Joseph, PhD Christopher Mill, BSc, MPH Moshe Ben-Shoshan, MD, MSc
Magdalena J. Grzyb, MD Ann Clarke, MD, MSc Nofar Kimchi Colette Lachaine Sebastian La Vieille, MD Lawrence Joseph, PhD Christopher Mill, BSc, MPH Moshe Ben-Shoshan, MD, MSc
Prehospital Administration of Epinephrine in Pediatric Anaphylaxis – a Statewide Perspective
Leslie M. Cristiano, MD Brian C. Hiestand, MD William A. Gower, MD Katherine C. Gilbert, MD Jason W. Caldwell, DO, FAAAAI Antonio R. Fernandez, PhD James E. Winslow, MD
Leslie M. Cristiano, MD Brian C. Hiestand, MD William A. Gower, MD Katherine C. Gilbert, MD Jason W. Caldwell, DO, FAAAAI Antonio R. Fernandez, PhD James E. Winslow, MD
Increase in Intensive Care Unit Admissions for Anaphylaxis in the United Kingdom 2008-2012
Deepan Vyas, MRCPCH Despo Ierodiakonou, MD PhD David A Harrison, MA PhD Tim Russell Paul J. Turner, FRACP PhD Robert J. Boyle, MBChB PhD
Deepan Vyas, MRCPCH Despo Ierodiakonou, MD PhD David A Harrison, MA PhD Tim Russell Paul J. Turner, FRACP PhD Robert J. Boyle, MBChB PhD
Anaphylaxis Fatalities in Australia 1997 to 2013
Raymond James Mullins, FRACP FRCPA PhD FAAAAI Woei Kang Liew, MD Brynn Wainstein, FRACP, PhD Elizabeth H Barnes, BAppSc, MStat Dianne E. Campbell, MD, FRACP, PhD
Raymond James Mullins, FRACP FRCPA PhD FAAAAI Woei Kang Liew, MD Brynn Wainstein, FRACP, PhD Elizabeth H Barnes, BAppSc, MStat Dianne E. Campbell, MD, FRACP, PhD
2209
Innovations in the Prediction and Treatment of Allergic Diseases
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
The Economic Burden of Food Allergic Patients Managing at a Tertiary Care Center
Narissara Suratannon, MD Panida Swangsak Jarungchit Ngamphaiboon, MD Pantipa Chatchatee, MD
Narissara Suratannon, MD Panida Swangsak Jarungchit Ngamphaiboon, MD Pantipa Chatchatee, MD
The Effect of Vitamin D Levels on Pediatric Allergic Diseases: A Nationwide Population-Based Study
Hea-Kyoung Yang Jaehee Choi Woo Kyung Kim So-Yeon Lee, MD Yong Mean Park Man-Yong Han, MD Myung-Il Hahm Yoomi Chae Hye-young Kim Kang Mo Ahn, MD Ho-Jang Kwon, MD PhD Jihyun Kim, MD
Hea-Kyoung Yang Jaehee Choi Woo Kyung Kim So-Yeon Lee, MD Yong Mean Park Man-Yong Han, MD Myung-Il Hahm Yoomi Chae Hye-young Kim Kang Mo Ahn, MD Ho-Jang Kwon, MD PhD Jihyun Kim, MD
Clinical and Epidemiological Differences in Patients with Acute Urticaria and Chronic Urticaria
Mehtap Haktanir Abul, MD Fazil Orhan Zekiye Ilke Kilic Topcu Taner Karakas Ali Baki
Mehtap Haktanir Abul, MD Fazil Orhan Zekiye Ilke Kilic Topcu Taner Karakas Ali Baki
Gender- and Genetic-Dependent Sunlight Exposure Effects on the Cumulative Incidence of Atopic Dermatitis during Infancy
Miwa Shinohara, M.D., Ph.D. Eiichi Ishii Kenji Matsumoto, MD, PhD
Miwa Shinohara, M.D., Ph.D. Eiichi Ishii Kenji Matsumoto, MD, PhD
Creating a System to Track Allergic Reactions in Schools
Ruchi Gupta, MD, MPH Marjorie Yarbrough, MPH Bridget Smith, PhD
Ruchi Gupta, MD, MPH Marjorie Yarbrough, MPH Bridget Smith, PhD
Impact of Maternal Oral Contraceptive Pills on Wheeze and Allergic Outcomes in 5-Year-Olds: A Prospective Birth Cohort Study in Japan.
Kiwako Yamamoto-Hanada, MD Limin Yang Tetsuo Shoda, MD, PhD Osamu Natsume, MD Masami Narita, MD PhD Yukihiro Ohya, MD, PhD
Kiwako Yamamoto-Hanada, MD Limin Yang Tetsuo Shoda, MD, PhD Osamu Natsume, MD Masami Narita, MD PhD Yukihiro Ohya, MD, PhD
Determination of the Accurate Food Allergy Prevalence and Correction of Unnecessary Food Elimination
Yuki Okada, MD Takumi Yamashita Hideki Kumagai Yoshihiko Morikawa Akira Akasawa, MD, PhD
Yuki Okada, MD Takumi Yamashita Hideki Kumagai Yoshihiko Morikawa Akira Akasawa, MD, PhD
Relationship of Influenza Virus Infection and Complications from Viral/Bacterial Infections in a Community Based Setting
Yitzchok M. Norowitz, BS Tamar A. Smith-Norowitz, PhD Stephan Kohlhoff, MD
Yitzchok M. Norowitz, BS Tamar A. Smith-Norowitz, PhD Stephan Kohlhoff, MD
The Association Between Maternal Depression and Child Allergic Disease
Ju-Suk Lee, MD PhD Cheol Hong KIm, MD Jin-A Jung, MD
Ju-Suk Lee, MD PhD Cheol Hong KIm, MD Jin-A Jung, MD
The Passive Smoking Is an Important Risk Factor of Allergic Diseases in Korean Adolescents
Kyung Suk Lee, MD, PhD Man-Yong Han, MD Jun-Hyuk Song, MD Sun Hee Choi, MD, PhD Yeong-Ho Rha, MD, PhD
Kyung Suk Lee, MD, PhD Man-Yong Han, MD Jun-Hyuk Song, MD Sun Hee Choi, MD, PhD Yeong-Ho Rha, MD, PhD
No Association Between Atopic Outcomes and Pertussis Vaccine Given in Children Born on the Isle of Wight 2001-2
Carina Venter, PhD RD Julia Stowe, BA (Hons) Nick Andrews, PhD Elizabeth Miller, FRCPath Paul J. Turner, FRACP PhD
Carina Venter, PhD RD Julia Stowe, BA (Hons) Nick Andrews, PhD Elizabeth Miller, FRCPath Paul J. Turner, FRACP PhD
2210
Immunotherapy, Anaphylaxis
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Epit Prevents from the Induction of Anaphylaxis to Further Allergens: Role of Naive Tregs
Lucie Mondoulet, PhD Vincent Dioszeghy, PhD Emilie Puteaux Mélanie Ligouis Véronique Dhelft Camille Plaquet Christophe Dupont, MD PhD Pierre-Henri Benhamou, MD
Lucie Mondoulet, PhD Vincent Dioszeghy, PhD Emilie Puteaux Mélanie Ligouis Véronique Dhelft Camille Plaquet Christophe Dupont, MD PhD Pierre-Henri Benhamou, MD
Altered Serum IgE and IgG4 Response to Dermatophagoides Pteronyssinus Allergens during Specific Immunotherapy
Baoqing Sun, MHA Zheng Peiyan
Baoqing Sun, MHA Zheng Peiyan
Conjunctival Provocation Test in Daily Practice: Four Ocular Symptoms Vs Ocular Pruritus Score System
Carmen Rondon, MD PhD Paloma Campo, MD PhD Esther Barrionuevo, MD, PhD Ana Prieto del Prado, MD Gador Bogas, MD Arturo Ruiz, MD Maria Auxiliadora Guerrero Leticia Herrero Pedro A Galindo Diana Perez-Alzate, MD Miguel Blanca, MD, PhD
Carmen Rondon, MD PhD Paloma Campo, MD PhD Esther Barrionuevo, MD, PhD Ana Prieto del Prado, MD Gador Bogas, MD Arturo Ruiz, MD Maria Auxiliadora Guerrero Leticia Herrero Pedro A Galindo Diana Perez-Alzate, MD Miguel Blanca, MD, PhD
House Dust Mite-Associated Allergic Rhinitis: Efficacy of STG320 Sublingual Tablets of House Dust Mite Allergen Extracts
Michel Roux, MD Hélène Nguyen, PharmD Agnès Viatte Robert K. Zeldin, MD
Michel Roux, MD Hélène Nguyen, PharmD Agnès Viatte Robert K. Zeldin, MD
A Complication of Eosinophilic Esophagitis from Sublingual Immunotherapy
Charmi Patel Prem K. Menon, MD FAAAAI
Charmi Patel Prem K. Menon, MD FAAAAI
Intralymphatic Pollen-Specific Immunotherapy for Nasal Allergy: Clinical Efficacy and Effects on the Induction of Pollen- Specific Antibody
Tetsuya Terada Syuji Omura Yusuke Kikuoka Megumi Yoshida Manabu Suzuki Shinpei Ichihara Takahiro Ichihara Takaki Inui Ryo Kawata
Tetsuya Terada Syuji Omura Yusuke Kikuoka Megumi Yoshida Manabu Suzuki Shinpei Ichihara Takahiro Ichihara Takaki Inui Ryo Kawata
Evaluation of SQ-House Dust Mite Sublingual Immunotherapy Tablet One-Year after Completion of a 24-Week Treatment Period
Petra U. Zieglmayer, MD Hendrik Nolte, MD, PhD Harold S. Nelson, MD FAAAAI David I. Bernstein, MD FAAAAI Amarjot Kaur, PhD Ziliang Li, PhD Rene Zieglmayer Rene Schmutz, MD Patrick Lemell, PhD Friedrich Horak, MD
Petra U. Zieglmayer, MD Hendrik Nolte, MD, PhD Harold S. Nelson, MD FAAAAI David I. Bernstein, MD FAAAAI Amarjot Kaur, PhD Ziliang Li, PhD Rene Zieglmayer Rene Schmutz, MD Patrick Lemell, PhD Friedrich Horak, MD
Efficacy of Sublingual Immunotherapy to Dust Mites: Real-Life Study Comparing Adults and Children
Carla Irani, MD FAAAAI Albert Semaan
Carla Irani, MD FAAAAI Albert Semaan
Eosinophilic Esophagitis Induced By Aeroallergen Sublingual Immunotherapy in an Enteral Feeding Tube Dependent Pediatric Patient
Cindy S Bauer, MD Michaela M Tvrdik Shauna Schroeder, MD
Cindy S Bauer, MD Michaela M Tvrdik Shauna Schroeder, MD
Efficacy of 300IR 5-Grass Pollen Sublingual Tablet in the Treatment of Rhinitis Symptoms in Polysensitized Subjects with Grass Pollen-Induced Allergic Rhinoconjunctivitis
Robert K. Zeldin, MD Yann Amistani, MSc Josiane Cognet-Sicé, PharmD Kathy Abiteboul, PharmD
Robert K. Zeldin, MD Yann Amistani, MSc Josiane Cognet-Sicé, PharmD Kathy Abiteboul, PharmD
Evaluation of Pediatric and Adult Systemic Reactions to Subcutaneous Immunotherapy (SCIT): Interim Analysis of a Retrospective Chart Review
Chen Lim, MD Cristina Sison, PhD Punita Ponda, MD
Chen Lim, MD Cristina Sison, PhD Punita Ponda, MD
Fel d 1 Peptide Immunotherapy Ameliorates Both Cat and Ovalbumin Responses, in a Dual Allergen Murine Model of Allergic Airways Disease
Daniel M. Moldaver Mantej S. Bharhani Christopher D Rudulier, PhD Jennifer Wattie Mark D. Inman, MD PhD Mark Larché, PhD
Daniel M. Moldaver Mantej S. Bharhani Christopher D Rudulier, PhD Jennifer Wattie Mark D. Inman, MD PhD Mark Larché, PhD
Endometrial Anaphylaxis Due to Subcutaneous Immunotherapy (SCIT): A Case Series
Manideep Nandigam Frank J. Eidelman, MD FAAAAI Ves Dimov, MD
Manideep Nandigam Frank J. Eidelman, MD FAAAAI Ves Dimov, MD
2211
Rhinosinusitis
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Surgical Therapy Reduces Blood Eosinophil Counts in Eosinophilic Chronic Rhinosinusitis
Dai Takagi Yuji Nakamaru Satoshi Fukuda
Dai Takagi Yuji Nakamaru Satoshi Fukuda
Clinical Characteristics of Aspirin Exacerbated Respiratory Disease in a Tertiary Care Patient Cohort
Whitney W. Stevens, MD PhD Anju T. Peters, MD FAAAAI Leslie C. Grammer, MD FAAAAI Kathryn E. Hulse, PhD Atsushi Kato, PhD Bruce Tan, MD Stephanie S. Smith, MD David B. Conley, MD Robert C. Kern, MD Pedro C. Avila, MD Robert P. Schleimer, PhD FAAAAI
Whitney W. Stevens, MD PhD Anju T. Peters, MD FAAAAI Leslie C. Grammer, MD FAAAAI Kathryn E. Hulse, PhD Atsushi Kato, PhD Bruce Tan, MD Stephanie S. Smith, MD David B. Conley, MD Robert C. Kern, MD Pedro C. Avila, MD Robert P. Schleimer, PhD FAAAAI
Clinical Characteristics of Patients with Chronic Rhinosinusitis without Nasal Polyps in a Tertiary Care Setting
Mariel G Rosati, MD Whitney W. Stevens, MD PhD Newton Li, MD Sumit Bose, MD Leslie C. Grammer, MD FAAAAI Kathryn E. Hulse, PhD Atsushi Kato, PhD Robert C. Kern, MD Bruce K. Tan, MD Stephanie S. Smith, MD David B. Conley, MD Pedro C. Avila, MD Robert P. Schleimer, PhD FAAAAI Anju T. Peters, MD FAAAAI
Mariel G Rosati, MD Whitney W. Stevens, MD PhD Newton Li, MD Sumit Bose, MD Leslie C. Grammer, MD FAAAAI Kathryn E. Hulse, PhD Atsushi Kato, PhD Robert C. Kern, MD Bruce K. Tan, MD Stephanie S. Smith, MD David B. Conley, MD Pedro C. Avila, MD Robert P. Schleimer, PhD FAAAAI Anju T. Peters, MD FAAAAI
Management of Adenoid Hypertrophy in Allergic Children, How Effective Is Surgery?
Omursen Yildirim, MD Yusuf O Ucal Andreea I. Popescu Mehmet F Sonmez Serhat A Erdogan
Omursen Yildirim, MD Yusuf O Ucal Andreea I. Popescu Mehmet F Sonmez Serhat A Erdogan
Expression of ADAM17 and ADAM10 in Nasal Polyps
Woo Yong Bae, MD Seong Kook Park, MD Dae Young Hur, MD Tae Kyung Koh, MD Ji Won Seo, MD
Woo Yong Bae, MD Seong Kook Park, MD Dae Young Hur, MD Tae Kyung Koh, MD Ji Won Seo, MD
Down-Regulated the Expression of Wdpcp Could Interrupt the Ciliogenesis in CRS
Yinyan Lai Yun Ma Jianbo Shi
Yinyan Lai Yun Ma Jianbo Shi
New Model of Murine Allergic Rhinosinusitis Induced Cockroach Allergens
Bethany L. Lussier, MD Daniel G. Remick, M.D.
Bethany L. Lussier, MD Daniel G. Remick, M.D.
Prolonged Allergen Exposure Causes TSLP-Mediated Th2-Skewing in Mouse Models of Chronic Rhinosinusitis
Dong-Kyu Kim, MD Kyung Mi Eun Hong Ryul Jin, MD Seong Ho Cho, MD FAAAAI Dae Woo Kim, MD
Dong-Kyu Kim, MD Kyung Mi Eun Hong Ryul Jin, MD Seong Ho Cho, MD FAAAAI Dae Woo Kim, MD
Fidarestat Decrease Allergic Sinus Congestion
Walter C. Spear, M.Sc. KarryAnne K. Belanger, B.Sc. Spotswood Miller, B.Sc. Igor Patrikeev, Ph.D Massoud Motamedi, PhD Kota V Ramana, Ph.D. Satish Srivastava, Ph.D. Bill T. Ameredes, PhD
Walter C. Spear, M.Sc. KarryAnne K. Belanger, B.Sc. Spotswood Miller, B.Sc. Igor Patrikeev, Ph.D Massoud Motamedi, PhD Kota V Ramana, Ph.D. Satish Srivastava, Ph.D. Bill T. Ameredes, PhD
2212
Cytokines, Chemokines and Innate Mechanisms
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
ATP8B1 Deficiency Enhances Hyperoxia-Induced Lipid Oxidation and Apoptotic Response in Lung Epithelial Cells
Andrew J. Cooke, MD Jutaro Fukumoto, MD and PhD Lee C Tan Richard F. Lockey, MD FAAAAI Narasaiah Kolliputi, PhD
Andrew J. Cooke, MD Jutaro Fukumoto, MD and PhD Lee C Tan Richard F. Lockey, MD FAAAAI Narasaiah Kolliputi, PhD
Modulation of Lung Inflammation and Airway Hypereactivity By the Toll-like Receptor 4 (TLR4) Agonist Glucopyranosyl Lipid a (GLA) in a Mouse Model of Airway Allergy
George Qian Samreen Arshad Dongling Chen Xiaying Wu Keith Graver Mayra Fernandez Joanne Schiding Timothy J Soos Christopher Arendt El-Bdaoui Haddad
George Qian Samreen Arshad Dongling Chen Xiaying Wu Keith Graver Mayra Fernandez Joanne Schiding Timothy J Soos Christopher Arendt El-Bdaoui Haddad
In Vitro and In Vivo Transglutaminase 2 Expression in Asthma and COPD
Gyu-Young Hur Jee Youn Oh Jae-Kyeom Sim Kyung Hoon Min Sung-Yong Lee Jae-Jeong Shim Kyung-Ho Kang
Gyu-Young Hur Jee Youn Oh Jae-Kyeom Sim Kyung Hoon Min Sung-Yong Lee Jae-Jeong Shim Kyung-Ho Kang
Anti-Interleukin (IL)-9 Antibody Increases Induction of Oral Tolerance in Murine Allergic Rhinitis
Soo Whan Kim Jihyun SHIN
Soo Whan Kim Jihyun SHIN
Reduced Nasal Brain Derived Neurotrophic Factor in Aspirin Exacerbated Respiratory Disease
Michele Pham, MD Rachel Baum, BS David Broide, MB,ChB, FAAAAI Andrew White, MD, FAAAAI Taylor Doherty, MD, FAAAAI
Michele Pham, MD Rachel Baum, BS David Broide, MB,ChB, FAAAAI Andrew White, MD, FAAAAI Taylor Doherty, MD, FAAAAI
Autolysosomal Formation Is Required for Autophagy-Dependent IL-18 Release from Airway Epithelial Cells.
Hiroki Murai, MD, PhD Shintaro Okazaki, MD Hisako Hayashi, MD, PhD Akiko Kawakita, MD Motoko Yasutomi, MD, PhD Sanjiv Sur, MD Yusei Ohshima, MD,PhD
Hiroki Murai, MD, PhD Shintaro Okazaki, MD Hisako Hayashi, MD, PhD Akiko Kawakita, MD Motoko Yasutomi, MD, PhD Sanjiv Sur, MD Yusei Ohshima, MD,PhD
MD2 Facilitates Pollen and Cat Dander-Induced Innate and Allergic Airway Inflammation
Koa Hosoki, MD, PhD Toshiko Itazawa, MD, PhD Istvan Boldogh, PhD Sanjiv Sur, MD
Koa Hosoki, MD, PhD Toshiko Itazawa, MD, PhD Istvan Boldogh, PhD Sanjiv Sur, MD
The Role of Autophagy in Allergic Inflammation: A New Target for Severe Asthma
Yoo Shin, MD PhD Jing-Nan Liu Youngwoo Choi Hae-Sim Park
Yoo Shin, MD PhD Jing-Nan Liu Youngwoo Choi Hae-Sim Park
Cat Dander Extract Requires Myd88 to Induce Innate Neutrophil Recruitment, and Allergic Sensitization and Allergic Airway Inflammation.
Toshiko Itazawa, MD, PhD Koa Hosoki, MD, PhD Istvan Boldogh, PhD Sanjiv Sur, MD
Toshiko Itazawa, MD, PhD Koa Hosoki, MD, PhD Istvan Boldogh, PhD Sanjiv Sur, MD
Cockroach Protease Induces Allergic Airway Inflammation Via IL-33 and TSLP Secretion By Epithelial Cells
Naveen Arora, Ph.D Sagar Laxman Kale Komal Agrawal Shailendra N. Gaur, MD FAAAAI
Naveen Arora, Ph.D Sagar Laxman Kale Komal Agrawal Shailendra N. Gaur, MD FAAAAI
Anti-type2-Antibodies Specifically Inhibit Murine Asthma Features Induced By Intranasal Application of IL-5 and IL-13
Hendrik Beckert Helen Meyer-Martin Stephanie Korn Sebastian Reuter Roland Buhl
Hendrik Beckert Helen Meyer-Martin Stephanie Korn Sebastian Reuter Roland Buhl
Peanut Agglutinin Is a Novel Receptor for Dendritic Cell-Specific Intercellular Adhesion Molecule-3-Grabbing Non-Integrin (DC-SIGN).
Madhan Masilamani, PhD Mohanapriya Kamalakannan, MSc Lisa Chang, BS Galina Grishina, MSc Hugh A. Sampson, MD FAAAAI
Madhan Masilamani, PhD Mohanapriya Kamalakannan, MSc Lisa Chang, BS Galina Grishina, MSc Hugh A. Sampson, MD FAAAAI
IL-25 Causes Airway Hyper-Responsiveness of Human Precision Cut Lung Slices from Donors with Asthma.
Jordan Heath, MD Richard Kurten, PhD Suzanne E House James D Sikes Megan Kurten Stacie M. Jones, MD Josh L. Kennedy, MD
Jordan Heath, MD Richard Kurten, PhD Suzanne E House James D Sikes Megan Kurten Stacie M. Jones, MD Josh L. Kennedy, MD
Cytokine Profiles in Breast Milk in Relation with Atopic Manifestations of Mothers and Infants: Study in Asian Population.
Sirapassorn Sornphiphatphong, MD Pantipa Chatchatee, MD Jarungchit Ngamphaiboon, MD Sirinuch Chomtho Nattiya Hirankarn Narissara Suratannon, MD
Sirapassorn Sornphiphatphong, MD Pantipa Chatchatee, MD Jarungchit Ngamphaiboon, MD Sirinuch Chomtho Nattiya Hirankarn Narissara Suratannon, MD
Individual and Synergistic Effects of IL-5 and IL-13 on Trans-Compartmental Activation and Migration of Eosinophils and Murine Asthma Features
Sebastian Reuter Helen Meyer-Martin Hendrik Beckert Stephanie Korn Roland Buhl
Sebastian Reuter Helen Meyer-Martin Hendrik Beckert Stephanie Korn Roland Buhl
Cardiolipin Provides a Platform for Caspase-1 Activation and NLRP3 Inflammasome Assembly
Suzanne L. Cassel, MD FAAAAI Eric Elliott Shankar S. Iyer, PhD Fayyaz Sutterwala, MD PhD
Suzanne L. Cassel, MD FAAAAI Eric Elliott Shankar S. Iyer, PhD Fayyaz Sutterwala, MD PhD
MyD88-Mediated Innate Immune Response in a Single Cat Dander Extract Challenge
John P. Kelley, MD Koa Hosoki, MD, PhD Sanjiv Sur, MD
John P. Kelley, MD Koa Hosoki, MD, PhD Sanjiv Sur, MD
Dust Mite-Induced Allergic Pulmonary Inflammation Is Differentially Regulated By Il33-/- and Il1rl1-/- Dendritic Cells.
Min Jung Lee, MD Eri Yoshimoto Li Li Yoshihide Kanaoka, MD PhD Nora A. Barrett, MD FAAAAI
Min Jung Lee, MD Eri Yoshimoto Li Li Yoshihide Kanaoka, MD PhD Nora A. Barrett, MD FAAAAI
Human Hemopoietic Progenitor Cell Toll-like and Thymic Stromal Lymphopoietin Receptor Expression and Function in Allergic Asthmatic Subjects
Damian Tworek, MD, PhD Delia Heroux, BSC Seamus N O'Byrne, MAAP Paul M. O'Byrne, MB, FRCPC, FRSC Judah A Denburg, MD, FRCPC, FAAAAI
Damian Tworek, MD, PhD Delia Heroux, BSC Seamus N O'Byrne, MAAP Paul M. O'Byrne, MB, FRCPC, FRSC Judah A Denburg, MD, FRCPC, FAAAAI
CCR8 Mediated Cell Migration Controls Th2 Differentiation
Caroline L. Sokol, MD PhD Ryan Camire Michael Jones Andrew D. Luster, MD PhD
Caroline L. Sokol, MD PhD Ryan Camire Michael Jones Andrew D. Luster, MD PhD
The Effect of Vitamin D Supplementation on Mucosal IL-5, MMP9 and Cathelicidin after Nasal Allergen Challenge with Grass Pollen
Natasha C. Gunawardana, MBBS, MA (Cantab), MRCP Gaynor Campbell, PhD Sarah Lindsley Elizabeth E Mann Peter J.M. Openshaw, MBBS, PhD, FRCP Sebastian L. Johnston, MD PhD Catherine M. Hawrylowicz Trevor Thomas Hansel, MD PhD
Natasha C. Gunawardana, MBBS, MA (Cantab), MRCP Gaynor Campbell, PhD Sarah Lindsley Elizabeth E Mann Peter J.M. Openshaw, MBBS, PhD, FRCP Sebastian L. Johnston, MD PhD Catherine M. Hawrylowicz Trevor Thomas Hansel, MD PhD
Group 2 Innate Lymphoid Cells: New Players in Peanut Allergy
Elisavet Ntavli Paul J. Turner, FRACP PhD Robert J. Boyle, MBChB PhD Andrew Clark, MRCPCH MD Abigail O Robb, B.Sc Stephen R. Durham, MA MD FRCP Mohamed H. Shamji, BSc MSc PhD FAAAAI
Elisavet Ntavli Paul J. Turner, FRACP PhD Robert J. Boyle, MBChB PhD Andrew Clark, MRCPCH MD Abigail O Robb, B.Sc Stephen R. Durham, MA MD FRCP Mohamed H. Shamji, BSc MSc PhD FAAAAI
2213
Mast Cells and Basophils
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Profiling the Immune Response to Peanut Using Mass Cytometry
Leticia Tordesillas, PhD Adeeb H. Rahman, PhD Hugh A. Sampson, MD FAAAAI M. Cecilia Berin, PhD
Leticia Tordesillas, PhD Adeeb H. Rahman, PhD Hugh A. Sampson, MD FAAAAI M. Cecilia Berin, PhD
A Case of Neuropathic Pain in Monoclonal Mast Cell Activation Syndrome
Jeannie L. Bay, DO Kaye E. Sedarsky, MD Maureen M. Petersen, MD
Jeannie L. Bay, DO Kaye E. Sedarsky, MD Maureen M. Petersen, MD
Acidic Conditions Regulate Mast Cell Migration and Fc Epsilon RI–Mediated Cytokine Production
Yosuke Kamide, MD, PhD Tamotsu Ishizuka, MD, PhD Hiroaki Hayashi, MD Chihiro Mitsui, MD Akio Mori, MD, PhD Takeshi Hisada, MD, PhD Kunio Dobashi, MD, PhD Fumikazu Okajima Masanobu Yamada, MD, PhD Masami Taniguchi, MD, PhD
Yosuke Kamide, MD, PhD Tamotsu Ishizuka, MD, PhD Hiroaki Hayashi, MD Chihiro Mitsui, MD Akio Mori, MD, PhD Takeshi Hisada, MD, PhD Kunio Dobashi, MD, PhD Fumikazu Okajima Masanobu Yamada, MD, PhD Masami Taniguchi, MD, PhD
Regulation of IL-4 Gene Expression By SIRT1 in Human Mast Cell
Yuji Nakamaru Dai Takagi Satoshi Fukuda
Yuji Nakamaru Dai Takagi Satoshi Fukuda
Hereditary Angioedema Is Associated with Neuropathic Pain, Systemic Lupus Erythematosis and Systemic Mastocytosis in an Analysis of a Health Analytics Claims Database
Chris Stevens Joseph C. Biedenkapp Robert Mensah Yung H. Chyung Burt Adelman
Chris Stevens Joseph C. Biedenkapp Robert Mensah Yung H. Chyung Burt Adelman
Anti-Apoptosis and Cell Survival Gene Expression Profile in LAD2 Cells
Arnold S Kirshenbaum, MD FAAAAI Maarten Leerkes, PhD Avanti Desai, MS Dean D. Metcalfe, MD FAAAAI
Arnold S Kirshenbaum, MD FAAAAI Maarten Leerkes, PhD Avanti Desai, MS Dean D. Metcalfe, MD FAAAAI
Transglutaminase 2 over-Expressed By Interaction of Mast Cells and Oligodendrocytes Induces Demyelination in the Experimental Autoimmune Encephalomyelitis
Gwan Ui Hong Young Min Ahn, MD Jai Youl Ro, Ph.D
Gwan Ui Hong Young Min Ahn, MD Jai Youl Ro, Ph.D
Inhibition of IgE-Mediated Allergic Reaction By Pharmacologically Targeting the Circadian Clock
Yuki Nakamura, PhD Atsuhito Nakao Shigenobu Shibata
Yuki Nakamura, PhD Atsuhito Nakao Shigenobu Shibata
Effect of ONO-4053 on Fc Epsilon RI Stimulated-Mast Cell Activation
Shinsuke Yamaguchi Yutaka Okada Yoko Matsunaga Fumio Nambu
Shinsuke Yamaguchi Yutaka Okada Yoko Matsunaga Fumio Nambu
Desensitization of Different Subsets of Mast Cells Associated with Different Manifestations of Food Allergy
Sara Benede, PhD M. Cecilia Berin, PhD
Sara Benede, PhD M. Cecilia Berin, PhD
The Role of the Mast Cell in the Anti-Viral Immune Response
Ruben Raychaudhuri Brian T. Kelly, MD MA Jennifer L Santoro, BS Mitchell H. Grayson, MD FAAAAI
Ruben Raychaudhuri Brian T. Kelly, MD MA Jennifer L Santoro, BS Mitchell H. Grayson, MD FAAAAI
Airway Basophils Are Activated and Associated with Eosinophilic Inflammation in Asthmatic Patients
Yoshihiro Suzuki, MD Keiko Wakahara, MD.PhD Tomoko Nishio, MD Satoru Ito, MD.PhD Yoshinori Hasegawa, MD.PhD
Yoshihiro Suzuki, MD Keiko Wakahara, MD.PhD Tomoko Nishio, MD Satoru Ito, MD.PhD Yoshinori Hasegawa, MD.PhD
Generation of Mast Cells in Co-Culture with Multiple Cell Types within an Advanced Allergy Tissue Model
Tahereh Derakhshan Rudra Bhowmick James H. Meinkoth Heather Gappa-Fahlenkamp
Tahereh Derakhshan Rudra Bhowmick James H. Meinkoth Heather Gappa-Fahlenkamp
Enhanced Development of Functional Murine Mast Cells in Human Stem Cell Factor Transgenic Immune-Deficient Mice
Kshitij Gupta, PhD Hariharan Subramanian, PhD Hydar Ali, PhD
Kshitij Gupta, PhD Hariharan Subramanian, PhD Hydar Ali, PhD
2214
Allied Health Saturday Poster Session
Session Details
Session Details
Saturday, March 5, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Peanut-Containing Products in Children's Hospitals: Putting Pediatric Patients at Risk
Laura A. Fletcher Tammy Pham Maguire Herriman Bridget Kiely Ruth Milanaik Gregory A. Rosner, MD
Laura A. Fletcher Tammy Pham Maguire Herriman Bridget Kiely Ruth Milanaik Gregory A. Rosner, MD
Hyperimmunoglobulin E Syndrome like Presentation in a Patient after Hemodialysis
Tanveer Singh, Resident Physician Brigani Amante David Regelmann, Attending Physician Noorpreet Dhawan
Tanveer Singh, Resident Physician Brigani Amante David Regelmann, Attending Physician Noorpreet Dhawan
Incidence of Delayed Systemic Reactions to Subcutaneous Immunotherapy
Carolyn M Ford, RN Elizabeth A. Leyvas, LVN Jill Waalen, MD, MPH Andrew A. White, MD FAAAAI
Carolyn M Ford, RN Elizabeth A. Leyvas, LVN Jill Waalen, MD, MPH Andrew A. White, MD FAAAAI
Pilot Study Identifies Obesity, Outdoor Air Pollution, and Tobacco Smoke Exposure As Contributors to High Estimated Prevalence of Risk of Asthma in Inner-City Schoolchildren from Pittsburgh Region
Tricia Morphew, MSc Jennifer Paden Elliott, PharmD Paige E. Dewhirst, MPH Nicole Pleskovic, BS Erica Butler, BS,CCRC David P. Skoner, MD Deborah A. Gentile, MD
Tricia Morphew, MSc Jennifer Paden Elliott, PharmD Paige E. Dewhirst, MPH Nicole Pleskovic, BS Erica Butler, BS,CCRC David P. Skoner, MD Deborah A. Gentile, MD
Characterization of Environmental Risk Factors Among Inner-City Schoolchildren with Physician Diagnosed Asthma from the Pittsburgh Region
Paige E. Dewhirst, MPH Jennifer Paden Elliott, PharmD Albert Presto, PhD Tricia Morphew, MSc Erica Butler, BS,CCRC Nicole Pleskovic, BS David P. Skoner, MD Deborah A. Gentile, MD
Paige E. Dewhirst, MPH Jennifer Paden Elliott, PharmD Albert Presto, PhD Tricia Morphew, MSc Erica Butler, BS,CCRC Nicole Pleskovic, BS David P. Skoner, MD Deborah A. Gentile, MD
Rate of Food Introduction after a Negative Oral Food Challenge in the Pediatric Population
Jessica Gau, NP CRC Sally A. Noone, RN MSN Zara Atal Jaime Ross, RN, MSN Jennifer Fishman, RN, BSN Beth D. Strong, RN CCRC Carly Ehritz, RN, MSN Julie Wang, MD FAAAAI
Jessica Gau, NP CRC Sally A. Noone, RN MSN Zara Atal Jaime Ross, RN, MSN Jennifer Fishman, RN, BSN Beth D. Strong, RN CCRC Carly Ehritz, RN, MSN Julie Wang, MD FAAAAI
Slit Adhesion in Brazilian People
Fernando M. Aarestrup, MD, PhD Beatriz Aarestrup Tamara A de Freitas Glaciele M M Rezende Nathalie J Guimarães e Silva Raissa M Cabrera
Fernando M. Aarestrup, MD, PhD Beatriz Aarestrup Tamara A de Freitas Glaciele M M Rezende Nathalie J Guimarães e Silva Raissa M Cabrera
Idiopathic Angioedema: Difficult Cases and Uncommon Findings
Laura E. Noonan, MSN, FNP-C Oral Alpan, M.D. Denise Loizou, RN Ozlem Goker-Alpan, M.D.
Laura E. Noonan, MSN, FNP-C Oral Alpan, M.D. Denise Loizou, RN Ozlem Goker-Alpan, M.D.
Specific Anti_A/B Immunoaffinity Chromatography Step Reduces Isoagglutinin Levels in an Intravenous Immunoglobulin Product
Alphonse P. Hubsch Annette Gaida Ibrahim El Menyawi Sandra Wymann Adriano Marques A. Nicole Spiegl Thomas Roten Eleonora Widmer
Alphonse P. Hubsch Annette Gaida Ibrahim El Menyawi Sandra Wymann Adriano Marques A. Nicole Spiegl Thomas Roten Eleonora Widmer
Food Allergen Labeling and Purchasing Habits in the US and Canada
Mary Jane Marchisotto Laurie Harada, BA Opal Kamdar, MD Bridget Smith, PhD Kemrani Khan Scott H. Sicherer, MD FAAAAI Stephen L. Taylor, PhD Veronica LaFemina Maria Antonella Muraro, MD PhD Susan Waserman, MD FAAAAI Ruchi Gupta, MD, MPH
Mary Jane Marchisotto Laurie Harada, BA Opal Kamdar, MD Bridget Smith, PhD Kemrani Khan Scott H. Sicherer, MD FAAAAI Stephen L. Taylor, PhD Veronica LaFemina Maria Antonella Muraro, MD PhD Susan Waserman, MD FAAAAI Ruchi Gupta, MD, MPH
High Rate of Uncontrolled Asthma Among Inner-City Schoolchildren from Pittsburgh Region
Erica Butler, BS,CCRC Nicole Pleskovic, BS Jennifer Paden Elliott, PharmD Paige E. Dewhirst, MPH Tricia Morphew, MSc David P. Skoner, MD Deborah A. Gentile, MD
Erica Butler, BS,CCRC Nicole Pleskovic, BS Jennifer Paden Elliott, PharmD Paige E. Dewhirst, MPH Tricia Morphew, MSc David P. Skoner, MD Deborah A. Gentile, MD
Characterizing Pediatricians' Management of Food Allergy to Improve Care Coordination
Alana Otto, MD Ashley Dyer, MPH Bridget Smith, PhD Ruchi Gupta, MD, MPH
Alana Otto, MD Ashley Dyer, MPH Bridget Smith, PhD Ruchi Gupta, MD, MPH
Comparative Effectiveness of Mepolizumab and Omalizumab in Severe Asthma: An Indirect Comparison
Gillian Stynes Sarah Cockle Necdet Gunsoy, Ph.D. Daniel C Park Jaro Wex Jenny Wilson Eric Bradford, M.D. Frank C. Albers, M.D., Ph.D. Rafael Alfonso-Cristancho, M.D., Ph.D., MSc
Gillian Stynes Sarah Cockle Necdet Gunsoy, Ph.D. Daniel C Park Jaro Wex Jenny Wilson Eric Bradford, M.D. Frank C. Albers, M.D., Ph.D. Rafael Alfonso-Cristancho, M.D., Ph.D., MSc
Multiple Selective Responders Should Not be Confounded with Cross-Intolerance to Nsaids
Natalia Blanca-López, MD PhD Diana Perez-Alzate, MD Inmaculada Doña, MD, PhD Maria Luisa Somoza, MD Cristobalina Mayorga, PhD María José Torres, MD, PhD Jose A Cornejo-Garcia, PhD Miguel Blanca, MD, PhD Gabriela Canto, MD, PhD
Natalia Blanca-López, MD PhD Diana Perez-Alzate, MD Inmaculada Doña, MD, PhD Maria Luisa Somoza, MD Cristobalina Mayorga, PhD María José Torres, MD, PhD Jose A Cornejo-Garcia, PhD Miguel Blanca, MD, PhD Gabriela Canto, MD, PhD
Epidemiology of Clinical Oral Food Challenges (OFC) at Baylor College of Medicine/Texas Children's Hospital (TCH) Food Allergy Program: A Retrospective Chart Review
Kwei Akuete, MD, MPH Danielle Guffey, MS Charles G Minard, PhD Maria G. Buheis, MD Kristin H. Dillard, MD I. Celine Hanson, MD FAAAAI Lenora M. Noroski, MD, MPH Filiz O. Seeborg, MD, MPH Carla M. Davis, MD FAAAAI
Kwei Akuete, MD, MPH Danielle Guffey, MS Charles G Minard, PhD Maria G. Buheis, MD Kristin H. Dillard, MD I. Celine Hanson, MD FAAAAI Lenora M. Noroski, MD, MPH Filiz O. Seeborg, MD, MPH Carla M. Davis, MD FAAAAI
Seasonal Allergies, How They Relate to Oral Allergy Syndrome (OAS) ?
Nicolle Cascone, RN Tara Shankar, MD Andrej A. Petrov, MD Merritt L. Fajt, MD
Nicolle Cascone, RN Tara Shankar, MD Andrej A. Petrov, MD Merritt L. Fajt, MD
The Use of an Interdisciplinary Team to Treat Eosinophilic Esophagitis (EoE) in a Pediatric Patient
Katie Kemp, RN Emily Weis, MD Brianne Schmidt, RD Kimberly Brown, PhD
Katie Kemp, RN Emily Weis, MD Brianne Schmidt, RD Kimberly Brown, PhD
Pooled Analysis of Patient Treatment Satisfaction from Five Hizentra Studies
Mikhail Rojavin, PhD Hirokazu Kanegane, MD, PhD Michael Borte Kohsuke Imai, MD, PhD Alphonse P. Hubsch Helena Soop Stephen R. Jolles, MD PhD
Mikhail Rojavin, PhD Hirokazu Kanegane, MD, PhD Michael Borte Kohsuke Imai, MD, PhD Alphonse P. Hubsch Helena Soop Stephen R. Jolles, MD PhD
10:45 AM-12:00 PM
2251
Allied Health: The Patient-Centered Specialist Program: Becoming a Medical Neighbor
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Workshop
Moderator:
Joan E. Hawkins , CMM
Learning Objectives:
- Discuss the development of the medical home model in primary care
- Discuss the integration potential between the allergist and the primary care provider
- Discuss the NCQA’s certification requirements and the path to certification
2301
World Allergy Forum: Role of Intolerance in Food Allergy
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, South Exhibit Hall G
1.25 CME/CE
Symposium
Primary Moderators:
Robert F. Lemanske Jr. , MD FAAAAI
Mario Sánchez-Borges , MD FAAAAI
Mario Sánchez-Borges , MD FAAAAI
Learning Objectives:
- Identify the worldwide patterns associated with food intolerances
- Describe the regimens used for tolerance inductions
- Describe new therapeutic options in prevention of food allergy worldwide
2302
Lessons from Performing Guideline-Driven, Evidence-Based Asthma Interventions in the Real World: Who Benefits?
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Petree Hall D
1.25 CME/CE
Symposium
Moderator:
Anne Markus , JD, PhD, MHS
Learning Objectives:
- Describe how to promote effective adaptation when developing an evidence-based intervention, such as ongoing dialogue between researchers and the target healthcare setting to respond to the needs of the clinic while monitoring fidelity to the intervention
- Discuss if evidence-based interventions remain effective when translated into populations and healthcare settings that differ from the parent trials, and identify what components may be needed to retain efficacy
- Identify and assess if evidence-based asthma interventions are cost effective when translated across several different healthcare settings with various insurance providers, and identify what elements payers are interested in supporting for potential intervention sustainability
2303
New Molecular Breakthroughs in the Study of Immunoglobulin E
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 404AB
1.25 CME/CE
Symposium
Moderator:
Donald W. Macglashan , MD PhD
Learning Objectives:
- Describe the molecular mechanisms of IgE production and activation of mast cells
- Discuss new opportunities for development of drugs that affect mast cell function
- Discuss the nature of post-translational modifications that regulate the activities of IgE
2304
Epithelium and Innate Immune Responses: Airways and Skin
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Theatre (Room 411)
1.25 CME/CE
Symposium
Moderator:
Robert P. Schleimer , PhD FAAAAI
Learning Objectives:
- Discuss that bitter and sweet taste receptors are present in multiple anatomic compartments and can serve as innate immune system sentinels
- Discuss the multiple roles that epithelial cells in the skin serve in host defense and regulators of inflammation
- Discuss that epithelial cells in the lung produce many secreted molecules that regulate innate and adaptive immune responses
2305
Epigenetic Mechanisms in Allergic Diseases
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 408A
1.25 CME/CE
Symposium
Moderator:
Kathleen C. Barnes , PhD FAAAAI
Learning Objectives:
- Discuss epigenetic mechanisms that regulate allergic disease
- Describe the difference between gene-environment interaction and epigenetics
- Discuss gene-environment interactions that regulate cytokine responses
2306
Managing Stinging Insect Allergy in the 21st Century
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Petree Hall C
1.25 CME/CE
Symposium
Moderator:
Dennis K. Ledford , MD FAAAAI
Learning Objectives:
- Describe the mechanism of tolerance development during venom immunotherapy
- Assess the indications for initiation and discontinuation of venom immunotherapy
- Evaluate the overlap between venom-induced anaphylaxis and mast cell disorders
2307
What Do I Do With These Abnormal Newborn Screening Results?
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 502A
1.25 CME/CE
Symposium
Moderator:
Lisa J. Kobrynski , MD MPH FAAAAI
Learning Objectives:
- Identify the incidence of SCID and survival outcomes after implementation of newborn screening programs
- Identify idiopathic lymphopenia, dilemmas and strategies for management
- Discuss various transplantation protocols and new experimental treatment options for SCID
2308
NHLBI's Clinical Asthma Research Network (AsthmaNet)'s Approach to Key Asthma Questions in Children and Adults
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level One, Concourse Hall Room 152
1.25 CME/CE
Symposium
Moderator:
James Kiley , PhD
Learning Objectives:
- Discuss individualized long-term controller therapy in toddlers with asthma
- Discuss the effect of acetaminophen versus ibuprofen on asthma exacerbations in children with asthma
- Discuss the potential role of airway microbiome on the effect of ICS on adult asthma
2311
Allied Health: Comorbidities of Atopic Dermatitis
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 407
1.25 CME/CE
Symposium
Moderator:
Sally A. Noone , RN MSN
Learning Objectives:
- Describe the systemic comorbidities associated with atopic dermatitis
- Identify the atopic dermatitis patients at highest risk for systemic comorbidities
- Discuss treatment considerations for atopic dermatitis and their impact on associated comorbidities
2312
Allied Health: Cutting Edge: Health Related Quality of Life and Allergy Disease
Session Details
Session Details
Saturday, March 5, 2016: 10:45 AM-12:00 PM
Convention Center, Level Two, Room 409AB
1.25 CME/CE
Symposium
Moderator:
Scott H. Sicherer , MD FAAAAI
Learning Objectives:
- Discuss the quality of life implications of various food allergy management approaches (including Oral Immunotherapy)
- Identify the role of the dietitian in assisting patients in maintaining or improving quality of life
11:00 AM-12:30 PM
Complementary and Alternative Practices in Allergy
Session Details
Session Details
Saturday, March 5, 2016: 11:00 AM-12:30 PM
Convention Center, Level One, Concourse Hall Room 153B
0.00 CME/CE
12:00 PM-1:30 PM
Adverse Reactions to Drugs, Biologic and Latex Committee
Session Details
Session Details
Saturday, March 5, 2016: 12:00 PM-1:30 PM
Convention Center, Level One, Concourse Hall Room 150A
0.00 CME/CE
12:15 PM-1:45 PM
2411
Allied Health Professional Assembly Business Meeting and Oral Abstract Session
Session Details
Session Details
Saturday, March 5, 2016: 12:15 PM-1:45 PM
Convention Center, Level Two, Room 503
Oral Session
1.25 CME/CE
Primary Moderators:
Nina A. Zimmermann , MSN RN ANP-BC AE-C
Sally A. Noone , RN MSN
Sally A. Noone , RN MSN
12:30 PM
12:45 PM
1:30 PM
Improving Asthma Outcomes through Systems Change: The Breathe Initiative
Claudia Guglielmo, MPA, AE-C
Claudia Guglielmo, MPA, AE-C
12:30 PM-1:30 PM
2501
Understanding the Immune Basis of Drug-Induced Skin Reactions TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 410
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the pathophysiology of drug-induced skin reactions
- Discuss the interaction of viruses and drugs in hypersensitivity reactions
2502
Epigenetics in Asthma TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 501A
1.00 CME/CE
Seminar
Learning Objectives:
- Describe DNA methylation and histone modifications that may be important in asthma pathogenesis
- Describe post-transcriptional gene regulation by microNRAs in asthma pathogenesis
- Discuss the applications of epigenetics in the diagnosis and therapy of asthma
2503
Immune Deficiency in CRS: Screening and Treatment TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 501B
1.00 CME/CE
Seminar
Learning Objectives:
- Describe the epidemiology of immune dysfunction in patients with chronic rhinosinusitis
- Discuss lower airway abnormalities in patients with chronic rhinosinusitis and immune dysfunction
2505
Latex Allergy: An Update for the Clinician TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 504
1.00 CME/CE
Seminar
Learning Objectives:
- Describe clinical immunology of latex allergy
- Describe diagnosis and management of latex allergy
- Describe changes in the hospital latex precautions
2506
Airway Epithelium as the interplay Between Type 2 Innate Lymphoid Cells (ILC2) and Th2 Immunity TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 505
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the role of epithelial cell-derived cytokines/immune modulators in chronic airway inflammation
- Describe the activity of epithelial cell-derived cytokines/immune modulators on ILC2 and allergic airways changes
2508
Managing Milk Allergy in Children TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 507
1.00 CME/CE
Seminar
Learning Objectives:
- Describe criteria for selecting an alternative formula in a milk-allergic infant
- Discuss and compare various hypoallergenic formulas
- Describe evaluation and monitoring for milk allergy in infants
2510
Mechanisms of Allergic Inflammation in Omenn Syndrome TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 511A
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the spectrum of gene mutations that can lead to expression of Omenn Syndrome
- Discuss and recognize potential mechanisms by which hypomorphic RAG mutations can lead to the expression of allergic manifestations in these patients
2511
Molecular Allergy Diagnosis: Does it Help in Managing Your Patient With Multiple Environmental and Food Allergies? TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 511B
1.00 CME/CE
Seminar
Learning Objectives:
- Describe the phenomenon of immunologic and clinical cross-reactivity
- Discuss and compare the current and future platforms for allergenic components testing
- Discuss the role of component testing in food and environmental allergy
2512
Challenging Cases in Venom Immunotherapy (VIT) TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 511C
1.00 CME/CE
Seminar
Learning Objectives:
- Identify the indications for initiation of VIT
- Discuss and appraise the evidence for the optimal duration of VIT
- Describe the evidence of mast cell disorder in patients with anaphylaxis from stinging insects
2551
Rhinovirus is More Important Than RSV in the Origin of Asthma
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 404AB
1.00 CME/CE
Pro/Con Debate
Moderator:
Steve N. Georas , MD
Learning Objectives:
- Discuss the asthma outcomes of rhinoviral infection
- Identify the asthma outcome of RSV infection
- Discuss the different effects of these common viral infections
2552
Are You Nuts? Peanuts Should Not be Removed From Schools and Other Public Places
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 408A
1.00 CME/CE
Pro/Con Debate
Moderator:
J. Andrew Bird , MD, FAAAAI
Learning Objectives:
- Identify the risks of public places (schools, airplanes) for peanut-allergic individuals.
- Describe the approaches to mitigating risk of peanut allergic reactions in public places.
2553
Allergen Immunotherapy: Dose Adjustment: Are They Needed for Local Reactions, Peaks of Season, Gaps in Treatment?
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 408B
1.00 CME/CE
Pro/Con Debate
Moderator:
Michael R. Nelson , MD PhD FAAAAI
Learning Objectives:
- Discuss whether immunotherapy doses need to be altered for local reactions during peak allergen season and if there is a gap in therapy, or maintained
- Discuss whether large local reactions predict anaphylaxis or not
2554
Imaging Immunity in Health and Disease
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Theatre (Room 411)
1.00 CME/CE
Symposium
Moderator:
William T. Shearer , MD PhD FAAAAI
Learning Objectives:
- Discuss how imaging can be utilized in allergy/immunology
- Discuss how imaging can be utilized to help with diagnosis and management of primary immunodeficiency
Allergic Fungal Respiratory Diseases Committee
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level One, Concourse Hall Room 153A
0.00 CME/CE
Asthma & Allergic Diseases in the Elderly Committee
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 301A
0.00 CME/CE
Core Curriculum, Education & Residency Review Subcommittee
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 308B
0.00 CME/CE
Genetics, Molecular Biology & Epidemiology Committee
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 306B
0.00 CME/CE
Health Informatics, Technology & Education Committee
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level One, Concourse Hall Room 150B
0.00 CME/CE
Interest Section Coordinating Committee
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 303A
0.00 CME/CE
JACI Associate Editors Meeting
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 304C
0.00 CME/CE
Occupational Diseases Committee
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
JW Marriott, Third Floor, Atrium 2
0.00 CME/CE
Office of Practice Management
Session Details
Session Details
Saturday, March 5, 2016: 12:30 PM-1:30 PM
Convention Center, Level Two, Room 304A
0.00 CME/CE
1:45 PM-2:45 PM
Committee on the Underserved Meeting
Session Details
Session Details
Saturday, March 5, 2016: 1:45 PM-2:45 PM
Convention Center, Level One, Concourse Hall Room 153C
0.00 CME/CE
2:00 PM-3:15 PM
2601
Asthma Featured Biologics
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Room 502B
Oral Session
1.25 CME/CE
Primary Moderators:
Caroline C. Horner , MD FAAAAI
Christopher C. Randolph , MD FAAAAI
Christopher C. Randolph , MD FAAAAI
2:15 PM
Efficacy of Reslizumab with Asthma, Chronic Sinusitis with Nasal Polyps and Elevated Blood Eosinophils
Steven F. Weinstein, MD, FAAAAI
Steven F. Weinstein, MD, FAAAAI
2:45 PM
Exploratory Analysis of the Roles of Multiple Biomarkers in Predicting Response to Omalizumab in Allergic Asthma
William W. Busse, MD FAAAAI
William W. Busse, MD FAAAAI
3:00 PM
2602
From the Bench to the Bedside, When Clinical and Basic Science Research Advance Clinical Care
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Theatre, Room 411
Oral Session
1.25 CME/CE
Moderator:
Antonella Cianferoni , MD PhD FAAAAI
2:15 PM
2:45 PM
2603
Respiratory Viruses, Illness and Asthma
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Room 502A
Oral Session
1.25 CME/CE
Primary Moderators:
Daniel J. Jackson , MD
Peter W. Heymann , MD
Peter W. Heymann , MD
2:00 PM
Upper Respiratory Infections during Infancy and Childhood Aeroallergen Sensitization and Asthma
Leilanie Perez Ramirez, MD MS
Leilanie Perez Ramirez, MD MS
2:30 PM
2:45 PM
3:00 PM
Interrogation of the Effects of Rhinovirus on Th2 Promoting Pathways in Allergic Asthma
Rachana Agrawal, Ph.D.
Rachana Agrawal, Ph.D.
2604
Drug Allergy Diagnosis and Management
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Room 515A
Oral Session
1.25 CME/CE
Primary Moderators:
David A. Khan , MD FAAAAI
Jean-Christoph Caubet , MD
Jean-Christoph Caubet , MD
2:00 PM
2:45 PM
2605
Mind the Education Gaps!
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Room 404AB
Oral Session
1.25 CME/CE
Primary Moderators:
Asriani M. Chiu , MD FAAAAI
Gerald B. Lee , MD
Gerald B. Lee , MD
2:00 PM
2:30 PM
Level of Knowledge, Concerns and Healthcare Practices Among Physicians Regarding E-Cigarettes
Venkatkiran Kanchustambham, MD
Venkatkiran Kanchustambham, MD
2:45 PM
2606
Rhinitis, Immunotherapy
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Room 408A
Oral Session
1.25 CME/CE
Primary Moderators:
Michael R. Nelson , MD PhD FAAAAI
Christopher W. Calabria , MD
Christopher W. Calabria , MD
2:00 PM
A Randomized Placebo-Controlled Trial of Intradermal Grass Pollen Immunotherapy for Seasonal Allergic Rhinitis
Anna D. Slovick, MRCS DOHNS MBBS BSc
Anna D. Slovick, MRCS DOHNS MBBS BSc
2:45 PM
IL-2 Mediates Generalized Tfh Downregulation during Allergen-Specific Immunotherapy
Véronique M. Schulten, PhD
Véronique M. Schulten, PhD
2607
Microbiome
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Room 406AB
Oral Session
1.25 CME/CE
Primary Moderators:
Nives Zimmermann , MD FAAAAI
Duane R. Wesemann , MD PhD
Duane R. Wesemann , MD PhD
2:00 PM
2:15 PM
2:30 PM
A Prospective Microbiome-Wide Association Study of Childhood Food Sensitization and Allergy
Jessica Rabe Savage, MD, MHS
Jessica Rabe Savage, MD, MHS
2:45 PM
3:00 PM
2608
New Approaches to Disease Modification and Prevention
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Room 408B
Oral Session
1.25 CME/CE
Primary Moderators:
Désirée E.S. Larenas Linnemann , MD FAAAAI
David W. Hauswirth , MD FAAAAI
David W. Hauswirth , MD FAAAAI
2:00 PM
2:15 PM
Immune Tolerance Induction Following AIT Is Associated with Induction of Circulating CD4+CXCR5+PD-1+FoxP3+ T Follicular Regulatory Cells
Hjh Hanisah Hj Awg Sharif, BHSc MSc
Hjh Hanisah Hj Awg Sharif, BHSc MSc
2:45 PM
3:00 PM
Could Allergen Immunotherapy be a Therapeutic Intervention in Eosinophilic Oesophagitis?
Moises A. Calderon, MD PhD
Moises A. Calderon, MD PhD
2611
Allied Health Travel Grant Recipients
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Room 409AB
1.25 CME/CE
Workshop
Moderator:
Stephen J. McGeady , MD FAAAAI
Learning Objectives:
- Discuss activates by Allied Health members which contribute to the overall care of patients
2612
Allied Health: Collecting and Managing Data from an Environmental Home Assessment
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level Two, Room 403A
1.25 CME/CE
Workshop
Moderator:
Susan L. Balcer-Whaley , MPH
Learning Objectives:
- Discuss various strategies for collecting environmental home assessments
- Identify equipment used for a home assessment
- Identify how environmental samples are collected, measured and managed
Federation of RSLAAIS Board of Governors Meeting
Session Details
Session Details
Saturday, March 5, 2016: 2:00 PM-3:15 PM
Convention Center, Level One, Concourse Hall Room 150C
0.00 CME/CE
3:30 PM-4:30 PM
2701
The Past, Present and Future of Asthma
Session Details
Session Details
Saturday, March 5, 2016: 3:30 PM-4:30 PM
Convention Center, Level One, South Exhibit Hall G
1.00 CME/CE
Keynote
Moderator:
Robert F. Lemanske Jr. , MD FAAAAI
Learning Objectives:
- Explain how knowledge gained over the last five decades has transformed the way allergy and asthma are diagnosed and treated
- Recognize the huge steps that have been made in unravelling the genetic code in determining new mechanisms and therapeutic targets for the treatment of allergy and asthma, the biological revolution
- Realize that we are at the start of a further revolution, the digitalization of biology and the convergence of the physical and biological sciences to create a new precision and personalized approach to chronic diseases such as asthma
4:45 PM-6:00 PM
2801
AAP: Hot Topics in Pediatric Allergy TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level One, Petree Hall C
1.25 CME/CE
Workshop
Moderator:
Elizabeth Matsui , MD MHS
Learning Objectives:
- Describe the latest developments in pediatric allergy and immunology
- Discuss how these latest developments might affect the care of pediatric patients
2802
Vocal Cord Dysfunction (VCD): More Common Than You Think
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 403B
1.25 CME/CE
Workshop
Moderator:
Mark F. Sands , MD FAAAAI
Learning Objectives:
- Discuss that VCD exists on a spectrum of airway disorders and is probably under-diagnosed in many patients with severe, difficult-to-control asthma
- Discuss a rational approach to VCD diagnosis, including characteristic features in history, physical exam and pulmonary function tests
- Describe an approach to VCD management via speech therapy
2803
How Allergic Immune Responses are Initiated and Regulated: The Role of Epithelial Cells and Immune System in Allergic Diseases
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 404AB
1.25 CME/CE
Workshop
Moderator:
Michiko K. Oyoshi , PhD MSc FAAAAI
Learning Objectives:
- Describe the role of epithelial cell-derived cytokines in the initiation and amplification of Th-2 immune responses
- Describe the relationship of epithelial cell-derived cytokines and allergic responses
- Discuss the unique challenges of targeting epithelial cell-derived cytokines in allergic disease
2804
Adherence Challenges in Asthma: Pediatrics, Adolescents and Older Adults
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 406AB
1.25 CME/CE
Workshop
Moderator:
Andrea J. Apter , MD MA MSc FAAAAI
Learning Objectives:
- Discuss issues of adherence to asthma medications unique for each age group
- Discuss how to approach patients about medication adherence
- Describe specific strategies to improve medication adherence in each age group
2805
Immune Deficiency Lurking in the Allergy Clinic
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 408A
1.25 CME/CE
Workshop
Moderator:
Seema Sharma Aceves , MD PhD FAAAAI
Learning Objectives:
- Distinguish allergy phenotypes from immune deficiencies
- Discuss primary immune deficiencies from the lens of a practicing allergist
2806
Chronic Rhinosinusitis in Children
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 408B
1.25 CME/CE
Workshop
Moderator:
Robert M. Naclerio , MD FAAAAI
Learning Objectives:
- Discuss aspects of CRS pathophysiology that are relevant to children
- Demonstrate particularities of CRS symptoms and clinical presentation in children
- Discuss pediatric aspects of medical treatment of CRS, the features, indications and contraindications of sinus surgery in children with CRS
2807
How Bronchial Smooth Muscle Cells Make Airways Hyper-Responsive
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 409AB
1.25 CME/CE
Workshop
Moderator:
Reynold A Panettieri , MD
Learning Objectives:
- Describe the effect of bronchial smooth muscle cells in AHR
- Describe signaling in smooth muscle cells and their effect on AHR
2808
Advances in Natural Killer Cell and Natural Killer T Cell Biology
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Theatre (Room 411)
1.25 CME/CE
Workshop
Moderator:
Antonella Cianferoni , MD PhD FAAAAI
Learning Objectives:
- Discuss specific signals that stimulate the activation of NKT cells so that they can modulate the innate and adaptive immune responses
- Discuss the spectrum of immunologic consequences that accrue in the setting of deficiency of NK cell function
- Describe the mechanisms that NK cells use to recognize immunologic targets
2809
Novel Biologicals for Asthma and Allergic Rhinosinusitis
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 502A
1.25 CME/CE
Workshop
Moderator:
Hirohisa Saito , MD PhD FAAAAI
Learning Objectives:
- Discuss novel biologicals in allergy and immunology
- Discuss mechanisms underlying novel immunologic therapies
2810
Clinical Implications of Microbiome in Chronic Respiratory Disease
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 502B
1.25 CME/CE
Workshop
Moderator:
Amber U. Luong , MD PhD
Learning Objectives:
- Discuss the deep sequencing technology, its limitations and consequences on the understanding of the microbiome, especially the limited understanding of the fungal microbiome
- Identify current knowledge of airway microbiota and outline how host-microorganism interactions influence health and disease
- Discuss how the microbiota in the mouth and nose influences the microorganism communities in the lungs and implications on disease
2811
ABAI: How to Use the ABAI WebPortal for Maintenance of Certification (MOC) Activities TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 503
1.25 CME/CE
Workshop
Moderator:
Stephen I. Wasserman , MD FAAAAI
Learning Objectives:
- Discuss the four major components of the ABAI MOC Program
- Discuss how to successfully report MOC activities to the ABAI using the WebPortal
- Demonstrate how to access, navigate and utilize the ABAI WebPortal for tracking and documenting personal progress through the MOC program
2812
A Comparison of HAE Guidelines: What's New? TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 515A
1.25 CME/CE
Workshop
Moderator:
Teresa Caballero , MD PhD
Learning Objectives:
- Discuss the multiple guidelines for the management of HAE
2813
NSAID-Exacerbated Respiratory Disease (NERD)
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 515B
1.25 CME/CE
Workshop - Panel Discussion
Moderator:
Marek L. Kowalski , MD PhD
Learning Objectives:
- Discuss and outline current knowledge and open questions in NERD
- Discuss knowledge gaps in the natural course of NERD
- Describe indications, contraindications and limitations of aspirin desensitization in asthma and nasal polyposis
2814
Problem-Based Learning: Doctor, Can You Prevent My Baby from Developing Peanut Allergy? TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 518
1.25 CME/CE
Workshop
Learning Objectives:
- Assess known risk factors for peanut allergy
- Appraise the results of the LEAP study
- Assess the screening for peanut allergy in infants at risk
2815
When Writing a Script Just Isn't Enough: Strategies to Overcome Barriers Associated with Poor Asthma Control in Older Adults
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level One, Concourse Hall Room 152
1.25 CME/CE
Workshop
Moderator:
Alan P. Baptist , MD MPH FAAAAI
Learning Objectives:
- Describe diagnostic and therapeutic approaches to the elderly asthmatic
- Describe the effect of financial concerns and medication related side-effects on asthma management in the elderly
- Explain how non-pharmaceutical interventions including pulmonary rehabilitation impact the elderly asthmatic
2816
FIT Workshop: Interesting Cases Part 1
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
JW Marriott, Platinum Ballroom Level, Salon C
1.25 CME/CE
Workshop
Primary Moderators:
T. Prescott Atkinson , MD PhD FAAAAI
Katherine E. Gundling , MD
Katherine E. Gundling , MD
Learning Objectives:
- Evaluate the management of challenging patient cases by trainees in allergy/imunology
- Compare and contrast management strategies for challenging patient cases with peers
2821
Allied Health: What Allied Health Professionals Need to Know about Drug Sensitivity
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 403A
1.25 CME/CE
Workshop
Moderator:
Sally A. Noone , RN MSN
Learning Objectives:
- Discuss methods to obtain an appropriate history of past and present drug reactions and analyze of temporal patterns between drug administration and onset of symptoms
- Identify the types of allergic reactions most often caused by various classes of drugs and objective testing for the diagnosis of drug allergy
2822
Allied Health: Skin Testing: Getting to the Point TICKETED
Session Details
Session Details
Saturday, March 5, 2016: 4:45 PM-6:00 PM
Convention Center, Level Two, Room 405
1.25 CME/CE
Workshop
Moderator:
Karol G. Timmons , RN MS CPNP
Learning Objectives:
- Discuss correct methods for application of skin tests in patients with obesity, tattoos and/or aging skin
- Discuss and adequately interpret skin testing in patients with obesity, tattoos and/or aging skin
- Describe the problems encountered with skin testing in patients who are obese, have tattoos or have aged skin
5:00 PM-6:00 PM
Practice Improvement Subcommittee
Session Details
Session Details
Saturday, March 5, 2016: 5:00 PM-6:00 PM
JW Marriott, Third Floor, Atrium 2
0.00 CME/CE
6:00 PM-7:00 PM
6:30 PM-8:30 PM
Evidence Of Severity: Patients at Risk
Session Details
Session Details
Saturday, March 5, 2016: 6:30 PM-8:30 PM
JW Marriott, Platinum Ballroom Level, Salon D
0.00 CME/CE
Targeting Exacerbations in Moderate to Severe Persistent Allergic Asthma
Session Details
Session Details
Saturday, March 5, 2016: 6:30 PM-8:30 PM
JW Marriott, Platinum Ballroom Level, Salon E
0.00 CME/CE
Sunday, March 6, 2016
6:30 AM-7:30 AM
JACI International Advisory Board
Session Details
Session Details
Sunday, March 6, 2016: 6:30 AM-7:30 AM
JW Marriott, Third Floor, Olympic 1
0.00 CME/CE
6:45 AM-7:45 AM
3001
Mast Cell Activation Syndrome(s): Diagnosis and Treatment TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 1
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss mast cell activation syndrome diagnosis
- Discuss mast cell activation syndrome treatment options
3002
Eosinophil Cytolysis: Programmed Death Pathways and Significance in Disease TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 2
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the role of pathologic eosinophil cell death in eosinophilic diseases
- Describe the power of clinical investigations as an in vivo approach to understand eosinophil biology
- Discuss the clinical value of analyzing eosinophil cytolysis including cell-free granules in sputum and tissue samples
3003
Chronic Rhinosinusitis: The Evidence Base for Current Treatments TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 3
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the current and future options of CRS treatment
- Describe the different types of CRS and the relevance of this distinction for therapy
- Describe the role of established medical treatments and discuss alternative options. Understand the indications for surgical treatment of FESS and its outcome
3004
Chronic Rhinosinusitis in Children TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 6
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the pathophysiology of chronic rhinosinusitis in children
- Discuss treatment strategies for chronic rhinosinusitis in children
- Discuss the surgical options for children with chronic rhinosinusitis who fail medical therapy
3005
Recurrent Infection in Adults TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 7
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the indications for an evaluation of the immune system in adult patients
- Describe the appropriate work-up for an immunodeficiency disorder in adults and how the changes in the immune response as people age might influence the results
- Discuss the treatment approaches for adult patients with primary immunodeficiency disease
3006
Exercise-Induced Anaphylaxis: Food-Dependent and -Independent TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 8
1.00 CME/CE
Seminar
Learning Objectives:
- Describe mechanism of EIA
- Identify common triggers in FDEIA
- Describe approach to diagnosis and management
3007
Helpful Advice in Improving Asthma Adherence TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 9
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the causes of non-adherence
- Identify the impact of non-adherence on control of asthma
- Identify effective strategies to improve adherence
3008
Mold: Facts & Fiction TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Diamond Ballroom Level, Salon 10
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss evidence that the risk of mold is often overstated, misstated or misunderstood
- Discuss the proven risk presented by mold
- Identify mycotoxins, mVOCs and current mold guidelines
3009
When Do You Give SLIT vs. SCIT? TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon A
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the advantages and disadvantages of SCIT vs. SLIT
- Describe the limitations of current evidence
- Discuss typical clinical scenarios where SLIT or SCIT would be preferable
3010
Nasal Allergen Provocation Test: A Real Challenge TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon B
1.00 CME/CE
Seminar
Learning Objectives:
- Describe the different methods for performing nasal allergen provocation test (NAPT) and the real dificulties and challenges
- Discuss the different methods of evaluation and sources of variability (extracts, protocols, etc)
- Discuss the applications in diferent entities and settings (diagnosis of local allergic rhinitis, clinical trials, research, private practice)
3011
Challenges in the Diagnosis and Treatment of Exercise-Induced Bronchoconstriction (EIB) TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon F
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss the diagnosis of EIB, including the use of provocative testing methods
- Discuss the current therapies for EIB
3012
AERD: More Than Asthma TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon G
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss mechanisms by which aspirin may modulate several types of respiratory disease
- Describe current approaches to diagnosis and avoidance of AERD
3013
Gene Therapy as a Treatment of Primary Immune Defects TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon H
1.00 CME/CE
Seminar
Learning Objectives:
- Discuss and analyze general information about gene therapy
- Discuss current indications for gene therapy in patients with primary immunodeficiency
- Evaluate considerations of future use of gene therapy in primary immunodeficiency disorders
3021
Allied Health: Tips and Tricks on Starting and Managing a Research Center TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon I
1.00 CME/CE
Seminar
Learning Objectives:
- Describe the resources needed to establish a research center
- Describe the challenges in maintaining a successful research center
3022
Allied Health: Lessons Learned from a Multidisciplinary Eosinophilic Esophagitis Clinic TICKETED
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon J
1.00 CME/CE
Seminar
Learning Objectives:
- Identify and build a multidisciplinary team to manage eosinophilic esophagitis (EoE)
- Discuss the needs of different patient populations in the management of EoE
Aerobiology Committee
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Third Floor, Plaza 1
0.00 CME/CE
Anaphylaxis committee meeting
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Platinum Ballroom Level, Salon C
0.00 CME/CE
Eosinophilic Gastrointestinal Disorders Committee
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
Convention Center, Level One, Concourse Hall Room 150A
0.00 CME/CE
Mast Cells Disorders Committee
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
Convention Center, Level One, Concourse Hall Room 153C
0.00 CME/CE
New Allergist/Immunologist Assembly Leadership Meeting
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Third Floor, Plaza 3
0.00 CME/CE
Practice, Diagnostics and Therapeutics Committee
Session Details
Session Details
Sunday, March 6, 2016: 6:45 AM-7:45 AM
JW Marriott, Third Floor, Olympic 3
0.00 CME/CE
7:00 AM-8:00 AM
3050
Are LABAs Safe in Asthma? Are They Effective?
Session Details
Session Details
Sunday, March 6, 2016: 7:00 AM-8:00 AM
Convention Center, Level One, Petree Hall D
1.00 CME/CE
Symposium
Moderator:
Stanley J. Szefler , MD FAAAAI
Learning Objectives:
- Review treatment positioning of LABA in asthma therapy and safety concerns
- Report on one segment of FDA LABA safety trials
- Discuss how to best use LABA in asthma
8:15 AM-9:45 AM
3101
Clinical Insights Into the Prevention and Modification of Atopic Disease
Session Details
Session Details
Sunday, March 6, 2016: 8:15 AM-9:45 AM
Convention Center, Level One, South Exhibit Hall G
1.50 CME/CE
Plenary
Moderator:
Stephen A. Tilles , MD FAAAAI
Learning Objectives:
- Discuss basic principles of immune tolerance, and how the timing of allergen exposure can exert a profound influence on subsequent sensitization and symptoms of food allergy in susceptible children
- Discuss new thinking about the mechanisms and consequences of skin barrier breakdown for atopic dermatitis and allergen sensitization, including how barrier function impacts microbial colonization, and is attenuated by new biologic therapies
- Discuss the effects of asthma exacerbation on disease natural history, including how new biologic therapies targeting eosinophils and Th2 pathways are providing unexpected new insights into disease pathobiology (an example of bidirectional translational research)
9:00 AM-11:00 AM
Hispanic American Allergy Asthma & Immunology Association, Meeting & Reception
Session Details
Session Details
Sunday, March 6, 2016: 9:00 AM-11:00 AM
JW Marriott, Platinum Ballroom Level, Salon A
0.00 CME/CE
9:45 AM-10:45 AM
3201
Asthma Genotypes, Phenotypes and Management
Session Details
Session Details
Sunday, March 6, 2016: 9:45 AM-10:45 AM
Convention Center, Level One, South Exhibit Hall H
Poster Session
0.00 CME/CE
Adolescent Asthmatics' Use of the Internet and Other Management Strategies
Ami Thakor Philipp, MD Alesia Hawkins Jones, PhD Howard Zeitz, MD Joseph S Yusin, MD FAAAAI
Ami Thakor Philipp, MD Alesia Hawkins Jones, PhD Howard Zeitz, MD Joseph S Yusin, MD FAAAAI
Relationship of Adherence Estimator TM Scores to Exhaled Nitric Oxide Levels in Pediatric Asthma Patients
Suzanne Burke-McGovern, MD Yan Yan Haesoon Lee Rauno Joks, M.D.
Suzanne Burke-McGovern, MD Yan Yan Haesoon Lee Rauno Joks, M.D.
Level of Knowledge, Concerns and Adherence to Asthma Management Guideline Recommendations Among Healthcare Providers in Midwestern USA
Jonathan M. Rodrigues, MD Carrie N. Caruthers, MD Josiah Moulton, DO Venkatkiran Kanchustambham, MD Roua Azmeh, MD Anthony Kruse, MD Roula Altisheh, MD Christopher Sutton, DO Mark S. Dykewicz, MD FAAAAI Raymond Slavin, MD FAAAAI
Jonathan M. Rodrigues, MD Carrie N. Caruthers, MD Josiah Moulton, DO Venkatkiran Kanchustambham, MD Roua Azmeh, MD Anthony Kruse, MD Roula Altisheh, MD Christopher Sutton, DO Mark S. Dykewicz, MD FAAAAI Raymond Slavin, MD FAAAAI
School Nurses' Perspectives on Barriers to Implementing School-Based Asthma Management Plans
Margee Louisias, MD Donald Goldmann Wanda Phipatanakul, MD MS FAAAAI
Margee Louisias, MD Donald Goldmann Wanda Phipatanakul, MD MS FAAAAI
Utilization and Outcomes Associated with Mobile-Based Asthma Action Plans Compared to Paper Asthma Action Plans Among Adolescents
Tamara T. Perry, MD Mallikarjuna R Rettiganti, PhD Jiang Bian, PhD Chunqiao Luo, MS Dennis E. Schellhase, MD Shemeka M. Randle, MS Rita H. Brown, BA Ariel Berlinski, MD Sarah A. Marshall, PhD
Tamara T. Perry, MD Mallikarjuna R Rettiganti, PhD Jiang Bian, PhD Chunqiao Luo, MS Dennis E. Schellhase, MD Shemeka M. Randle, MS Rita H. Brown, BA Ariel Berlinski, MD Sarah A. Marshall, PhD
Developing a Tool to Evaluate Patient-Provider Communication & Patient Satisfaction in Adult Asthma Management
Chloe L. Russo, MD Todd Lasch Alana Steffen Susan Corbridge, PhD, APN Sharmilee M. Nyenhuis, MD FAAAAI
Chloe L. Russo, MD Todd Lasch Alana Steffen Susan Corbridge, PhD, APN Sharmilee M. Nyenhuis, MD FAAAAI
Evaluation of the Efficacy of a Web-Based Work-Related Asthma Educational Tool
Joshua C. Lipszyc, BA MSc Simeon Gotsev, BSc Jack Scarborough Gary M. Liss, MD MS FRCPC Samir Gupta, MD MSc FRCPC Susan M. Tarlo, MBBS FAAAAI
Joshua C. Lipszyc, BA MSc Simeon Gotsev, BSc Jack Scarborough Gary M. Liss, MD MS FRCPC Samir Gupta, MD MSc FRCPC Susan M. Tarlo, MBBS FAAAAI
Four Different Phenotypes of Bhr Changing Pattern in School Children and It's Risk Factors
Young-Ho Kim, MD Eun Lee Song-I Yang Hyun-Ju Cho, MD Hyung-Young Kim Ji-Won Kwon, MD Young Ho Jung, MD Byoung-Ju Kim Ju-Hee Seo, MD Hyo-Bin Kim, MD, PhD So-Yeon Lee Ho-Jang Kwon, MD PhD Soo-Jong Hong, MD, PhD
Young-Ho Kim, MD Eun Lee Song-I Yang Hyun-Ju Cho, MD Hyung-Young Kim Ji-Won Kwon, MD Young Ho Jung, MD Byoung-Ju Kim Ju-Hee Seo, MD Hyo-Bin Kim, MD, PhD So-Yeon Lee Ho-Jang Kwon, MD PhD Soo-Jong Hong, MD, PhD